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ABSTRACT 
 
Brockman, Trisha Lynn. M.S., Department of Biological Sciences, Wright State 
University, 2014. 
Binding and entry mechanisms of adenovirus in polarized epithelial cells. 
 
 
 Adenovirus’s primary receptor, the Coxsackievirus and adenovirus receptor 
(CAR), has two transmembrane isoforms with differential localization within polarized 
epithelial cells (CAREx7 (basolateral), CAREx8 (apical)). I hypothesized that each isoform 
of CAR is degraded at different rates and is regulated by Src-family kinases. Increasing 
or decreasing the concentration of CAR is predicted to directly alter adenoviral entry. To 
test this hypothesis, inducible Madin Darby Canine Kidney (MDCK) cell lines either 
expressing CAREx7, CAREx8, or mCherry, under a doxycycline-inducible promoter were 
used in pulse-chase structured experiments to calculate the half-lives of these proteins. 
Alternatively, a polarized model lung epithelium (CaLu-3) treated with Src-kinase 
inhibitor, PP2, was used to test apical CAREx8 expression and viral transduction. Though 
CAREx7 and CAREx8 did have varying half-lives (5.1 h, 2.0 h respectively), inhibiting 
Src-family kinases did not decrease CAREx8 expression at early time points but did 
diminish adenovirus transduction. These data confirm that Src does not play a role in 
CAR turnover, but remains critical for adenoviral infection. 
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CHAPTER 1. INTRODUCTION 
	  
1.1 Adenovirus 
 Adenoviruses are respiratory pathogens that threaten the health of both civilian 
and military populations, causing up to 5-10% of reported “common cold” cases [1].  
Adenovirus infections can cause gastroenteritis, conjunctivitis, cystitis, and respiratory 
distress.  Typically in healthy individuals, adenovirus infections are self-resolving, 
however, in more severe cases such as immunocompromised individuals, adenovirus 
infections can result in the onset of acute respiratory disease and even death [2].  
 Adenoviruses are non-enveloped viruses containing a 36 kb linear double 
stranded DNA genome (Fig. 1).  Upon infection, adenoviruses genome does not integrate 
into the host genome.  It is due to this lack of genomic integration between virus and host 
that makes adenoviruses a potential and ideal vector for gene therapy.  Currently, the 
pitfall with using adenovirus as a vector to mediate gene therapy within the lung is the 
inability for the virus to infect host cells efficiently [3]. 
 Receptor abundance and accessibility help to determine the tropism and 
pathogenicity of a virus [3-5].  Viral infection occurs after the initial binding of the virus 
to its primary receptor on the target cell of the host. The more accessible a receptor is to a 
virus, the greater the chance of infection. If the primary receptor is inaccessible to the 
virus, then viral infection is prohibited, as is the case for adenovirus in the lung 
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Figure 1. Structure of adenovirus.     
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epithelium [3].  Most adenoviruses co-opt host epithelia by binding to the Coxsackievirus 
and Adenovirus Receptor (CAR), their primary receptor [6]. The fiber-knobs of 
adenovirus bind tightly to CAR in the initial virus attachment step, while integrins 
facilitate adenoviral entry upon binding the penton base (Fig. 1) [7]. However, tissues  
lacking CAR expression show resistance to adenovirus infection, even in the presence of 
integrins, demonstrating that CAR is crucial for the binding of adenovirus to the host cell 
[5, 8].  Therefore the presence or absence of CAR can greatly alter host susceptibility to 
adenoviral infection. Adenoviral binding and entry has been widely studied in non-
polarized cells; however the mechanism for apical infection of polarized epithelia is only 
beginning to be elucidated.  
 
1.2  Coxsackievirus and adenovirus receptor (CAR) 
 The coxsackievirus and adenovirus receptor is the primary receptor for most 
adenoviruses and can function as an attachment site for adenovirus serotypes from 
subgroups A, C, D, E, F, and G [1, 6].  CAR abundance has been closely associated with 
efficient adenovirus transduction [9-12].   
 CAR is a single pass type I transmembrane glycoprotein composed of two 
extracellular immunoglobulin domains (D1 and D2), a single hydrophobic α-helical 
transmembrane domain, and an intracellular region [6]. In polarized epithelial cells the 
extracellular immunoglobulin domain, D1, of CAR is involved in homophilic cell-cell 
adhesion and tissue genesis [11, 13-16]. CAR-CAR homophilic interactions between 
epithelial cells are crucial for maintaining tissue integrity in the heart and in the tight 
junctions of polarized epithelia.  CAR-CAR interactions are so important in establishing
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Figure 2. The two transmembrane isoforms of CAR; CAR
Ex7
 and CAR
Ex8
, 
and isoform specific C-terminal protein sequence.  (X) indicates the binding site 
for adenovirus fiber knob, junction adhesion molecule like protein (JAM-L), and  
homophilic binding site of other CAR proteins found on adjacent cells.  
CAREx7 – VAAPNLSRMGAIPAQSKDGSIV     (26aa) 
CAREx8 – FKYPYKTDGITVV     (13aa) 
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26 aa 
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tissue polarity that the knockout of CAR is embryonically lethal at approximately day 10 
of gestation due to loss of intercalated disc formation in the heart [16].  The D1 domain 
of CAR is not only responsible for homophilic interactions, but forms heterophilic 
interactions with the leukocyte-specific protein junction adhesion molecule like (JAM-L). 
CAR is also the attachment site of the adenovirus fiber knob [17, 18] and is involved in 
CAR dependent cell-cell communication [12, 19].   
 In the past, two main protein isoforms of CAR have been described: CAREx7 and 
CAREx8. These isoforms result from the alternative splicing of the mRNA encoded by the 
CXADR gene (Fig. 2) [9].  The CAREx7 spliceform is a result of mRNA splicing that 
terminates at the end of the seventh exon of CXADR. The CAREx8 spliceform is a result 
of splicing of the mRNA from a cryptic splice site within the middle of the seventh exon 
of CXADR to the eighth exon and terminates at the end of exon 8, thus leading to two 
distinct mRNAs that encode proteins with unique C-termini. The protein structure of 
CAREx7 and CAREx8
 
are identical except for the last 26 (CAREx7) or 13 (CAREx8) amino 
acids (aa) of the intracellular C-terminus [9].   
 The most abundant isoform of CAR (CAREx7) localizes to the basolateral surface 
of polarized epithelial cells beneath the tight junctions, where it is inaccessible to 
adenovirus (Fig. 3A) [9, 11, 20]. An outstanding question has been how people become 
initially infected with an adenovirus entering from the airway lumen if the primary 
receptor is sequestered at the basolateral surface.  Several mechanisms have been 
proposed: 1) a breach in the epithelial barrier by way of a transient or sustained break in 
the tight junctions; 2) the binding of adenovirus to a secondary receptor (e.g. αVβ3
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Tight  
Junction 
A. 
Polarized 
Epithelium 
CAREx7 
Apical 
Basolateral 
Polarized 
Epithelium 
Tight  
Junction 
CAREx8 
CAREx7 
Apical 
Basolateral 
B. 
SAC 
Figure 3. Accessibility of CAR to adenovirus entering from the lumen of the 
airway.  A. CAR
Ex7
 localizes beneath the tight junctions at the basolateral surface of 
polarized epithelia.  This results in the absence of receptor on the apical surface; 
therefore, no infection takes place.  B. CAR
Ex8
 at the apical surface allows for 
adenovirus internalization and infection of cells from the airway lumen. 
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and αVβ5 integrins); 3) cytokines released upon infection of resident host macrophages 
promote infection of the airway epithelia; or 4) increased apical abundance of CAR [21]. 
 Recently, Excoffon et al., 2010 have described an alternative low abundance 
isoform of CAR (CAREx8) that is spliced to include an eighth exon [9].  CAREx8 localizes 
at the apical surface or just beneath the apical surface in the subapical compartments 
(SAC) of polarized airway epithelia (Fig. 3B).  CAREx8 has been shown to act as a 
receptor for adenovirus and is able to mediate viral infection from the apical surface of 
polarized epithelia.  Endogenous CAREx8 abundance at the apical surface of polarized 
epithelia appears to be sufficient to media viral infection; however, the protein is found in 
such low abundance that viral infection remains low.  Increasing the amount of CAREx8 at 
the apical surface has been shown to increase viral transduction efficacy [9, 22].  This 
suggests that gene therapy efficacy or, alternatively, host susceptibility to adenoviral 
infection can be altered by manipulating the levels of apical CAREx8. My thesis is focused 
on understanding the endogenous regulation and turnover of the CAREx8 isoform. 
 
1.3 Protein turnover 
 Half-life refers to the amount of time it takes for half of the protein synthesized 
within a certain period of time to reach one half of its original concentration within the 
cell. Half-lives are unique for every protein. Some may be long, such as articular 
cartilage collagen, with a half-life of ~117 years [23]. Others are short, such as ornithine 
decarboxylase, with a half-life of 11 min [24].  The half-life can vary even between two 
different isoforms of the same protein.  For example, murine Sirt3 protein has three 
known isoforms each with variable half-lives [25]. Half-lives are also affected by post-
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translational modifications and interactions. Proteins are broken down by proteolysis, 
which results in smaller polypeptides or individual amino acids.  Proteolysis is involved 
in the regulation of some physiological and cellular processes preventing the 
accumulation of regulatory, unwanted, or abnormal proteins.  Proteins are degraded in the 
lysosome, proteasome, or by autophagy.  Degradation in the proteasome is generally 
considered a ubiquitin-dependent process [26].    
Knowing the turnover rate of a protein within a cell can aid in both the 
understanding and identification of how that protein is regulated. Little is known about 
the regulation of CAREx8 in the cell. Identifying the half-life of CAREx8 as well as the 
turnover rate of CAREx8 at the apical surface of polarized epithelia will be one of the first 
steps in determining the mechanisms by which CAREx8 is regulated.  Understanding how 
CAREx8 is regulated will help to decipher why some tissues may be more susceptible to 
adenovirus infection than others.  Knowing how long it takes for a protein to be 
synthesized and degraded will aid in identifying critical time frames in which clinicians 
can transiently overexpress CAREx8 for optimal gene therapy with an adenovirus vector 
without increasing the patient’s susceptibility to wild type adenovirus or suppressing 
other immunological functions.   
 
1.4 Src-family kinases: 
 The Excoffon lab has shown that the C-terminal sequence difference between the 
two isoforms of CAR results in their differential localization in polarized cells [9, 22]. 
Much is known about how CAR interacts with adenovirus [7]. In contrast, fewer studies 
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have been directed towards unraveling the native biological function of CAR and its 
regulation.  
The variance between the cytoplasmic tails of the two specified isoforms of CAR 
contains potential sites for differential phosphorylation. Phosphorylation of a protein is a 
posttranslational regulatory modification, wherein serine (S), threonine (T), or tyrosine 
(Y) residues are covalently linked to a phosphate group. Protein phosphorylation is 
performed by proteins known as kinases, which add phosphate groups, and is reversed by 
phosphatases, which remove phosphate groups. Phosphorylation is known to alter the 
localization, behavior, and often, interactions between proteins. The C-terminus of CAR 
contains several putative phosphorylation sites [27, 28] . The variations of amino acids 
between the C-terminus of CAREx7 and CAREx8 are likely to be the distinguishing factor 
between the regulation of the two isoforms, resulting in the apical localization of CAREx8. 
 Recently, Src-family kinases (SFK), a group of non-receptor tyrosine kinases 
made up of nine family members, c-Src, Lck, Hck, Fyn, Frk, Yes, Blk, Lyn, and Fgr, 
have been shown to play a role in viral infections [21, 29-32].  Mainou and Dermody 
showed that reovirus infection decreased when Src-family kinases were inhibited [32].  
They concluded that Src-family kinases help traffic internalized viruses to the 
endosomes, however, when Src-family kinases were inhibited, the internalized virus was 
sent to the lysosome for degradation thus resulting in decreased reovirus infection. 
Similarly, Lütschg et al., 2011 saw decreased adenovirus infection when Src-family 
kinases were inhibited [21]. They attributed decreased adenovirus infection to decreased 
αvβ3 integrin expression (a secondary receptor for adenovirus) at the apical surface of the 
epithelia. Following in suit, a similar decrease in coxsackie B virus infection was seen 
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with Src-family kinase inhibition of intestinal epithelial cells [29] and placental 
trophoblasts [31].  Inhibiting Src-family kinases potentially plays several roles in viral 
infection: 1) decreased receptor abundance or localization; 2) inhibits viral 
internalization; or 3) alters trafficking and processing of the virus.   
 In a recent study, Mruk et al. proposed a novel regulatory protein complex 
containing desmoglein-2, desmocollin-2, zona occludin-1 (ZO-1), c-Src, and CAR at the 
cell-cell interface of sertoli germ cells [33].  When both desmoglein-2 and desmocollin-2 
were knocked down, there was a mislocalization of c-Src, CAR, and ZO-1 at the tight 
junctions resulting in weak cell-cell adhesion.  They were also able to show that CAR and 
c-Src co-immunoprecipitate together.  These data suggest that CAR may be regulated by 
c-Src or, alternatively, CAR may regulate c-Src in some way.   
In this thesis, my focus is to analyze the pathways that Src-family kinases use to 
regulate CAR expression at both the basolateral and apical surface of polarized epithelial 
cells and how this affects adenovirus sorting upon apical entry.   
 
1.5 Rationale 
 It is important to study the regulation of CAR and the mechanisms governing 
adenovirus entry in order to advance adenovirus-mediated gene therapy, which is 
hindered due to the limited accessibility of apical CAR to adenoviruses entering the 
airspace or lumen of the airway epithelium.  Mechanisms that result in increased primary 
receptor concentrations will increase the clinical efficacy of adenovirus-based gene 
therapy techniques. Conversely, it is unclear what increases the susceptibility of the 
airway to pathogenic adenovirus infection.  Mechanisms that result in decreased primary 
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receptor concentrations will decrease the susceptibility of an individual to adenovirus 
infection and reduce the spread of wild type adenovirus either within vulnerable 
populations or during an outbreak of a highly virulent adenoviral strain.   
 
1.6 Hypotheses and specific aims 
 The ultimate goal is to better understand the endogenous mechanisms that 
regulate both CAREx7 and CAREx8 expression, abundance, localization, and degradation 
in polarized epithelial cells and how this alters adenoviral infection. I hypothesize: 
CAREx8 is tightly regulated by Src-family kinases and maintains a shorter half-life than 
CAREx7.   
 Here, in these studies, I have taken an investigative approach to studying CAR 
expression and adenoviral transduction using polarized epithelial cells (MDCK stable cell 
lines (doxycycline-induced to express CAREx7, CAREx8, or mCherry); CaLu-3 cells).  The 
chosen cell lines are ideal models for these studies due to three distinguishing properties: 
all are epithelial cell lines expressing endogenous CAR(Ex7 and Ex8), all are capable of 
polarizing, and all can be manipulated by standard molecular procedures (Fig. 4). 
Although many studies have been done with CAR, the half-life of CAR as well as the 
half-life of its specified isoforms remains a mystery.  Moreover, the inhibition of Src-
family kinases (SFK) has recently been shown to decrease adenovirus, coxsackie B virus, 
and reovirus infection in epithelial cells, however, the mechanisms remain unclear [21, 
29, 32] .  
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 In these aims I Aim 1.) determine the half-life of CAREx7 and CAREx8. Aim 2.) 
determine whether the inhibition of Src-family kinases alters adenoviral infection by 
interfering with the protein expression and localization of CAREx8.   
 These aims will begin to address how CAREx8 is regulated within the cell and how 
adenoviruses can take advantage of the differential regulation between the two specific 
isoforms. 
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Figure 4. Doxycycline (Dox) inducible MDCK cells able to stably express:  A. 
CAR
Ex8
 or B. CAR
Ex7
 as determined by Western blot, relative to the control 
housekeeper protein actin, or C. mCherry (a red fluorescent protein), as 
observed using a 4x lens on a Nikon fluorescence microscope, upon the addition 
of doxycycline. 
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Chapter 2. Materials and Methods 
 
2.1 Materials 
Antibodies 
Anti-actin and -RmcB (anti-CAR; extracellular domain which is identical to both 
CAR isoforms) were obtained from Millipore (Bedford, MA), Anti-FLAG was purchased 
from Sigma-Aldrich (St Louis, MO). The mouse anti-GFP was from Clontech 
(Mountainview, CA). The anti-V5, anti-ZO-1, rabbit anti-GFP, and the fluorescently-
labeled secondary antibodies came from Invitrogen (Carlsbad, CA). Anti-MAGI-1 was 
from Novus Biologicals (Littleton, CO). The anti-Src antibodies came from Cell 
Signaling (Danvers, MA). Horse-radish peroxidase-labeled secondary antibodies were 
obtained from Jackson ImmunoResearch (West Grove, PA). Rabbit anti-CAR-1605 
(recognizes the C-terminus in common to both isoforms) and anti-CAREx8-5678 (specific 
to the last 13 aa of CAREx8) have previously been described [9].  
 
Cell lines 
 The three main cell lines used: 1)  HeLa cells expressing shRNA for either 
scrambled (control; non-specific vector) or c-Src kinase (gift from Dr. Terry Dermody, 
Vanderbilt University); 2)  MDCK parental cells (ATCC, Rockville, MD) were used to 
generate three stable cell lines able to express either FLAG-tagged CAREx7, FLAG-
tagged CAREx8, or red fluorescent protein mCherry under a doxycycline (Dox) inducible 
promoter (24 h, 100 ng/ml Dox for expression) (Fig. 4) using the Lenti-X Tet-On
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 advanced inducible expression system (Clontech. Cat no: 632162) according to the 
manufacturer’s protocol (produced by Dr. Abimbola Kolawole under the supervision of 
Dr. Katherine JDA Excoffon, Wright State University); and 3)  CaLu-3 cells (ATCC, 
Rockville, MD), were cultured under standard conditions (DMEM (Invitrogen) with 10% 
FBS, 1 mM NEAA, 1 mM Sodium Pyruvate, Amphotericin B), (MEM (Invitrogen) with 
5% FBS tetracycline negative (PAA Lab, Dartmouth, MA)) or (RPMI1640 (Hyclone) 
with 10% FBS, 25 mM HEPES (Hyclone)), and 1% penicillin/streptomycin (Fisher), 
respectively. 
 
Viral vectors, chemical inhibitors, and activators 
 Adenovirus vectors carrying either the β-galactosidase reporter gene (AdV-β-
Gal), or the green fluorescent protein (GFP) reporter gene (AdV-GFP), were from the 
University of Iowa Vector Core, Iowa City, IA. The inhibitors and activators used in the 
study are listed in Table 1.  
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Inhibitors & 
Activators Target Vendor Catalog # 
Cycloheximide Protein synthesis inhibitor Sigma-Aldrich C7698-1G 
Genistein Tyrosine protein kinases Sigma-Aldrich G6649-5MG 
PP1 Src-family kinases Sigma-Aldrich P0040-5MG 
PP2 Src-family Kinases Sigma-Aldrich P0042-5MG 
Src-Activator Src-family kinases Santa Cruz Biotech Sc-3052 
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.  List of chemical inhibitors and activators 
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2.2 Methods 
Cell culture maintenance 
Cell culture techniques were performed under a laminar flow hood using sterile, 
biohazard level 2+ techniques. Cell cultures were stored and grown in 25- or 75-cm2 
tissue culture flasks within a humidified incubator at 37ºC and 5% CO2. Used media-
serum mix was discarded and new media-serum mix was added, based upon a pH change 
from 7.1 to about 6.0, as indicated by a color change of the media from pink to yellow or 
depending on confluency of cells. As cells began to divide and reached about 80% 
confluency, as observed under 400X total magnification with an inverted microscope, the 
cell cultures were divided into new flasks using a ratio of between 1:5 and 1:20 cells to 
media after removing attached cells with 0.25% Trypsin-EDTA (Mediatech, Inc., 
Manassas, VA). All flasks were supplied with new media-serum mix to a final volume of 
5 ml in a 25-cm2 tissue culture flask and 10 ml in a 75-cm2 tissue culture flask. Cell 
viability was verified before each experimental set using the trypan blue exclusion test 
[34]. Dead cells appeared blue since their membranes had become permeable to the 
trypan blue dye. Cell viability above 80% was considered acceptable for use in future 
experiments. 
 
Determination of cell concentration (hemocytometry) 
The following technique was used during cell seeding before transfections and 
adenovirus infections. Adherent monolayers of cells were trypsinized from 1-2 flasks and 
combined in a 50 ml centrifuge tube. The tube was centrifuged at 150 rcf for 5 min. at 
4ºC. The supernatant was aspirated and the cells were resuspended in 1 ml of culture 
medium and mixed gently by pipetting up and down. A clean coverslip was centered on a 
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hemocytometer between the outside railings over the two counting grids. A drop of well-
mixed cell suspension was placed at each notch. The drop was added once to ensure an 
even distribution of cells. Cells were then counted with a push button counter using 400X 
total magnification. Cells were counted in the four corner squares (1 mm X 1 mm) of the 
cytometer. These squares were 1/400 mm2. The average value of the total cells counted in 
the 4 squares was multiplied by 104 to determine the number of cells per milliliter. The 
volume of the mixture was adjusted by dilution with culture media to an appropriate 
concentration, depending on the demands of the particular assay. 
 
Brightfield and fluorescence microscopy  
 Brightfield and fluorescence microscopy were used to observe and optimize the 
experimental cellular growth conditions for CaLu-3 cell epithelial monolayers that had 
either been infected with an adenovirus carrying the green fluorescent protein reporter 
gene (AdV-GFP; MOI 100; 1 h)  or induced with doxycycline to overexpress the red 
fluorescent protein mCherry (MDCK mCherry stable cells; 100ng/ml Dox; 24 h) as a 
control for the MDCK stable cell lines. Brightfield and fluorescence images were 
obtained from a NIKON Eclipse TE2000-S fluorescent microscope at a magnification of 
10X. 
 
Western blot 
Cell cultures were placed on ice for 5 min, washed with ice-cold PBS, and lysed 
in a buffer solution (50 mM Tris pH 7.4, 150 mM NaCl, 1% Triton X-100, protease 
inhibitors (20 µg/ml, leupeptin, aprotinin, 10 µg/ml pepstatin, and 17.4 µg/ml 
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phenylmethylsulfonyl fluoride)) by rocking at 4°C for 10 min. Cells were scraped into a 
tube, sonicated five times with 5 pulses using a Sonic Dismembrator (Fisher Scientific, 
model 100) and centrifuged at 14,000 X g for 10 min at 4°C. The supernatant was 
transferred to fresh tubes and subjected to protein estimation by Bio-Rad protein assay 
according to the manufacturer’s instructions. Cell lysates were treated with ((1 µL)/(3 µL 
lysate)) 4 X denaturing buffer with dye (for WB) and incubated in a heat block at 65°C 
with shaking at 300 rpm for 10 min. The samples were then immediately vortexed 
vigorously before spinning at 17,000 rcf for 30-60 sec. Cell lysates were subjected to 
SDS polyacrylamide gel electrophoresis (SDS-PAGE) (using a 12% polyacrylamide gel 
unless otherwise indicated). The proteins on the polyacrylamide gel were transferred to a 
polyvinylidene difluoride membrane (PVDF) (Millipore, Bedford, MA), blocked with 5% 
BSA in tris-buffered saline tween-20 (TBS-T), washed, and probed with an appropriate 
antibody diluted in 5% BSA in TBS-T with sodium azide, followed by probing with 
HRP-conjugated secondary antibodies (Jackson Immuno Research, West Grove, PA) 
diluted in TBS-T (1:10,000). Protein bands were detected by adding ECL reagents 
(Pierce, Rockford, IL) for 1 min and imaged on a Fuji LAS 4000 and/or developed in an 
X-ray Medical film processor model Konica SRX 101. 
 
Adenovirus infection 
Adenovirus serotype 5 containing the β-galactosidase gene (AdV-β-Gal) or eGFP 
(AdV-GFP) driven by the CMV promoter (University of Iowa Vector Core, Iowa City, 
IA) was diluted with OptiMem culture media (Gibco, Invitrogen) without serum to the 
multiplicity of infection (MOI) of 100 plaque forming units (pfu) per cell. Growth media 
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was aspirated from cells that had been seeded for 24 to 48 hours, depending on the 
experiment, and the cells were rinsed with phosphate buffered saline containing calcium 
and magnesium (PBS+/+). 250 µL of diluted adenovirus was added to each well in a 24-
well plate (3 ml in 10 cm2 dish) at an MOI of approximately 100 plaque forming 
units/cell (PFU/cell), unless otherwise indicated, and incubated for 1 h at 37°C and 5% 
CO2 with gentle swirling every 15 min. The inoculum was then removed, cells were 
rinsed with OptiMem, and fresh media was added. Cells were incubated at 37°C with 5% 
CO2 until further analysis was conducted. 
 
Beta-galactosidase assay 
The Galacto-Light Plus System (Applied Biosystems, USA) was used to analyze 
adenovirus-mediated beta-galactosidase activity according to the manufacturer’s 
directions. Briefly, cells were lysed 24 hours after infection with an adenovirus carrying 
the β-galactosidase reporter gene (AdV-β-Gal). 120 µL of lysis buffer was added to each 
well in a 24-well plate for 20 min at room temperature. Cells were scraped and 2 µL of 
lysate was added into a 96-well plate followed by 100 µL of a 100X dilution of Galacton-
Plus substrate and 60 min incubation at room temperature. Enzyme activity was 
terminated in congruence with the light emission of the cleaved substrate being triggered 
upon the addition of 150 µL of Accelerator-II immediately before measuring the β-
galactosidase luminescence with an Optima Luminometer. Protein concentration was 
determined by adding 6 µL of lysate into a cuvette, followed by the addition of 1 ml Bio-
Rad reagent diluted (1:10 with double distilled water (ddH2O)). The mixture was 
incubated at room temperature for 10 min and the optical density was determined with a 
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spectrophotometer set to 595 nm, using a standard blank as a programmed baseline.  Each 
experiment was performed in 4-6 biological replicates and lysis buffer was used as a 
negative control. Data were analyzed by the two-tailed Student’s T-test, one-way analysis 
of variance (ANOVA), with Tukey’s or Dunnett’s post hoc test (Prism, GraphPad) or as 
described in the text. 
 
Cell surface biotinylation 
Cell surface proteins were biotinylated with 3 ml per 100 mm plate of 1 mg/ml 
sulfo-NHS-biotin (Cat # 21331 Thermo Scientific, Rockford, IL) for 1 h at 4°C after first 
cooling the cells on ice for 10 min and washing with ice cold PBS +/+. After washing the 
cells again with ice cold PBS +/+, any unreacted biotin was quenched with ice cold 100 
mM glycine for 20 min at 4°C. Washed cells were then incubated with lysis buffer for 
another 20 min at 4°C. The cell lysate was then immunoprecipitated with NeutrAvidin 
ultra link resin (Cat # 53150 Thermo Scientific) and subjected to Western blotting with 
an antibody of interest.  
 
Total cellular RNA extraction 
 Total cellular RNA was extracted from treated and control cells using TRIzol
 
Reagent (Invitrogen Life Technologies, Carlsbad, CA). Gloves were worn throughout the 
experiment with frequent changing and ribonuclease (RNase)-free materials were used in 
an RNase-free environment [35, 36]. Cells were centrifuged for 5 min. at 12,000 rcf at 
room temperature. The supernatant was discarded. The cells were lysed with 1 ml of cold 
Trizol reagent by repeatedly pipetting up and down.  The contents of the tube were 
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allowed to stand at room temperature for 5 min. to permit the dissociation of 
nucleoprotein complexes. Chloroform (0.2 ml) was added to each tube and the tubes were 
capped securely. The tubes were shaken vigorously by hand and then allowed to sit for 3 
min. at room temperature. The tubes were spun at 12,000 rcf for 15 min. at 4°C. The 
aqueous layer, which contains the RNA, was transferred to new centrifuge tubes. 
Isopropanol (0.5 ml) was added into each tube. The contents were gently mixed and 
incubated at room temperature for 10 min. These were centrifuged at 12,000 rcf for 10 
min. at 4°C. The supernatant was aspirated. The RNA pellet was washed with 1 ml 75% 
ethanol, vortexed, and centrifuged at 7,500 rcf for 5 min. at 4°C. All of the ethanol was 
removed, without drying the RNA pellet completely. The RNA pellet was dissolved in 
30% diethyl pyrocarbonate (DEPC)-treated ddH2O by passing the solution through a 
pipette tip and incubating for 10 min. at 55-60°C. The solutions were then transferred to 
RNase-free Eppendorf tubes. The purity and concentration of the extracted RNA were 
determined via nanodrop in CGR (Thermo Scientific). Pure RNA has a 260:280 nm 
reading equal to 2.0. The extracted RNA was stored at -80°C. 
 
Polymerase chain reaction (PCR) RT-PCR 
 The designed primers for the two CAR isoforms and MAGI-1 mRNA were 
purchased from Integrated DNA Technologies (Coralville, IA) and used for RT-PCR in a 
two-step RT-PCR system (Invitrogen Life Technologies, Carlsbad, CA). RNA samples 
taken from the extracted total RNA from each cell line were used as templates for reverse 
transcription into cDNA using the reverse transcriptase enzyme (Invitrogen). 1% cDNA 
and 10% of each primer were added to 0.2 ml, nuclease-free, thin-walled PCR reaction 
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tubes on ice. The reaction mixtures were placed in a preheated and programmed personal 
Master Thermal cycler (Eppendorf, Westbury, NY) for gene amplification using Taq 
DNA polymerase (New England BioLab Inc. Ipswich, MA). The conditions that were 
programmed in the thermal cycler included 1 cycle of incubation for DNA synthesis at 
94°C for 2 min. The PCR amplification was programmed for 35 cycles at 94°C for 15 sec 
(denaturation), 55oC for 15 sec (annealing), and 72°C for 45 sec (extension). The final 
extension cycle was programmed for 5 min. at 72oC.  
 
Regular PCR 
 This was performed at several instances during the study to confirm correct 
inserts during the process of cloning the DNA plasmids, using bacterial colonies as 
templates, as described above.  
 
Quantitative PCR (qPCR) 
 RNA was isolated using TRIzol (Invitrogen). cDNA was synthesized from the 
same starting amount of RNA using the Quanta First Strand Kit from Quanta 
BioSciences (Gaithersburg, MD). The PCR amplification program for this protocol was 
designed to contain 40 cycles at 95oC for 30 sec (denaturation), 58oC for 30 sec 
(annealing), and 74°C for 1 min. (extension). The final extension cycle was programmed 
for 10 min. at 74°C. qPCR was performed using SYBR Green with low ROX (Quanta, 
Gaithersburg, MD; 10% master mix qPCR reaction contained 2 µl cDNA, 2X reaction 
buffer with dNTPs, Accusat Taq DNA polymerase, MgCl2 ROX reference dye and 
SYBR green dye that binds specifically to dsDNA) in Stratagene's Real Time PCR 
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System (Agilent Technologies) using 3000p software v2.0.1 for data analysis.  
 
Analysis of PCR products 
PCR products were analyzed for the presence of specific DNA fragments by 
running 20 µL of the sample on 1.5% agarose gels made in TAE buffer. The molecular 
weight markers (MWM) used were 1 kb and 2 log DNA (New England BioLab Inc. 
Ipswich, MA) according to the relative sizes of CAR, mCherry, and other junction 
proteins used as controls. The electrophoresis apparatus was run for 30 min at 110 V. 
DNA sizes in the PCR products were estimated by comparing the position of the bands of 
interest to the closest band on the MWM. 
 
MTT assay 
 CaLu-3 cells were seeded in a 96 well plate and treated with increasing 
concentrations of either DMSO (24 h), chemical inhibitor PP2 (24 h), or 
paraformaldehyde (15 min) then assayed for cell viability via [3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide] (MTT) assay).  A 4 mM MTT solution was 
prepared by adding 16.57 mg of MTT (a yellow powder) to 10 ml of PBS then syringe 
filtered under sterile conditions (a pale yellow solution).  30 µL of the 4 mM MTT 
solution was added to cells still overlaid with 100ul of media without phenol red and 
placed in the incubator for 4 h.  Mitochondrial dehydrogenase enzymes of viable cells 
cleave the tetrazolium rings of the pale yellow MTT and form dark blue formazan 
crystals.  The formazan crystals were solubilized by adding 100 µl of 0.08 N HCl in 
isopropanol to each well and pipetting vigorously.  Absorbance of converted dye was 
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measured at a wavelength of 570 nm with background subtraction at 630 nm on a 
microtiter plate reader.  Each experiment was performed in 4-6 biological replicates.   
 
Half-life protein extraction 
 In a pulse chase structured experimental design, MDCK stable cells	   expressing	  
CAREx7,	   CAREx8,	   or	   mCherry	   under	   a	   doxycycline	   (Dox)	   inducible	   promoter were 
seeded in plastic six-well plates at 4x104 cells per well and allowed to attach for a 
minimum of 12 h.  The cells were then induced with doxycycline [100 ng/ml] for 24 h to 
express the protein of interest.  The cells were then washed with PBS+/+ and then 
replaced with FBS tetracycline negative (FBS tet (-)) media, and for some experiments, 
the media also contained the protein synthesis inhibitor cycloheximide (CHX) (30 µg/ml) 
as indicated in the text.  Immediately after the media was replaced, the harvest time 
points began respectively labeled as the time harvested post doxycycline removal (0, 4, 6, 
8, 10, 12, and 24 h or as indicated in the text) where 0 h is immediately after doxycycline 
removal and 24 h is 24 h after doxycycline removal.  The lysates/protein levels were 
analyzed via Western blotting.  Experimental model shown in Figure 5.  A similar 
experimental design was used for CAR turnover at the apical surface and was examined 
via cell surface biotinylation and Western blot or adenovirus infection via β-galactosidase 
assay (Fig. 6).  
 
Half-life quantitation analysis  
 Western blot band densities were quantified using ImageJ software, then 
normalized to their respective actin bands.  Using GraphPad Prism, half-life graphs were 
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formatted by plotting the normalized values using a plateau followed by a one phase 
exponential decay [37].  The plateau was determined by the GraphPad Prism software.  
Protein half-lives were calculated using the following methods [37]: 
 
 
 
  
 
 
Statistical analysis 
 Microsoft Excel and GraphPad Prism V5 (La Jolla, CA) were used to perform 
statistical analyses. Significant differences were analyzed using one-way or two-way 
ANOVA tests, followed by Tukey or Dunnett post hoc test to determine individual 
differences between control and experimental conditions. Data are represented by Mean ± 
SEM. Results were considered to be statistically significant if a p<0.05 was obtained. 
 
𝑁(𝑡) = 𝑁!𝑒!!"  
	  
ln(𝑁) − ln(𝑁!) = −𝑘𝑡   →   𝑇! !! =
ln  (2)
𝑘  
	  
Equation 1. Determination of rate constant k, and 
half-life. 
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Figure 5. Pulse chase model for identifying CAR
Ex7
 and CAR
Ex8
 half lives 
using the doxycycline-inducible MDCK stable cell lines.  A. MDCK cells 
stably expressing Flag-tagged CAR
Ex7
, CAR
Ex8
 or mCherry (a red fluorescent 
protein; control) under a doxycycline promoter were seeded on a plastic 12-well 
dish in FBS tet (-) media.  The cells were permitted to settle and attach to the 
plate for approximately 24 h.  B. The cells were then induced (i.e. turned on) 
with 100 ng/ml doxycycline in FBS tet (-) media for 24 h.  C. After 24 h of 
exposure to doxycycline, the doxycycline containing media was removed and 
replaced with standard conditioned FBS tet (-) media (Aim: 3.2.4 and 3.2.5) or 
FBS tet (-) media supplemented with 30 ng/ml cycloheximide (a protein 
synthesis inhibitor) (Aim: 3.2.6).   D. The cells were then lysed at increasing 
time points:  0 h (immediately after Dox removal), 4 h, 8 h, 10 h, 12 h, or 24 h 
hours post doxycycline removal.  E. Western blot analysis of the protein lysates 
was performed.  The blots were then probed with rabbit anti-Flag antibody or 
anti-actin to determine the amount of protein expression and rate of degradation 
relative to a housekeeping protein. 
Seed Cells Dox [100ng/ml] 
24h 24h 
0h 4h 8h 24h 10h 12h 6h 
Harvest Cells 
24h 
A. B. C. D. E. 
Western 
Blot 
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Figure 6.  Pulse chase model for identifying i.) apical CAR
Ex8
 turnover; and ii.) 
adenovirus transduction as CAR
Ex7
 and CAR
Ex8
 degrades, using doxycycline-
inducible MDCK stable cell lines.  A. MDCK cells stably expressing Flag-tagged 
CAR
Ex7
, CAR
Ex8
 or mCherry (a red fluorescent protein; control) under a 
doxycycline promoter were seeded on a plastic i.) 6-well or ii.) 24-well dish in FBS 
tet (-) media.  The cells were permitted to settle and attach to the plate for 
approximately 24 h.  B. The cells were then induced (i.e. turned on) with 100 ng/ml 
doxycycline in FBS tet (-) media at increasing time points over the course of 24 h. 
Each condition was permitted to express for 24 h in the presence of doxycycline.  
C. After 24 h of exposure to doxycycline, the doxycycline containing media was 
removed at increasing time points over the course of 24h and replaced with 
standard conditioned FBS tet (-) media.  D. At the last time point (T0:0 h) all the 
cells were either i.) apically labeled with biotin on ice (as described in materials 
and methods); or ii.) transduced with AdV-β-Gal (MOI 100) for 1 h.  E. i.) 
Isolated-biotinylated proteins  were analyzed by Western blot (Aim 3.2.5); ii.) cells 
were analyzed for β-Gal activity 24 h later via β-Galactosidase assay (Aim 3.2.8). 
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Chapter 3. Coxsackievirus and adenovirus receptor half-life 
3.1 Rationale 
 Protein turnover plays an important role in cellular processes.  The half-life of a 
protein will help to determine how stable and tightly regulated that protein is.  Knowing 
the turnover rate of a protein can help in determining exposure periods and working 
concentrations of therapeutic treatments aimed at manipulating the levels of that 
particular protein.  Proteins with several isoforms may have different half-lives due to 
differential regulation at many different levels such as gene expression, transcript 
abundance and splicing, translation, post-translational modifications, protein-protein 
interactions, and localization. It was hypothesized that CAREx8 will have a shorter half-
life than CAREx7.  To test this hypothesis, stable cell lines expressing one of the 
following: Flag-tagged CAREx7, CAREx8, or the red fluorescent protein (RFP) mCherry, 
under the control of a doxycycline-inducible promoter (Fig. 4); were used in pulse chase 
structured experiments to determine the half-lives of each protein (Fig. 5).  
 
3.2 Results 
3.2.1 Doxycycline is not toxic to the MDCK stable cells.  
  Doxycycline is an antibiotic that may have toxic effects on mammalian cells 
in high doses.  Since cell viability and the ability to maintain junction integrity is 
important for most of my experiments, I first tested if doxycycline showed toxicity to the 
MDCK stable cells.  The cells were treated with increasing concentrations of 
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 doxycycline for 24 h or formaldehyde (positive control) for 15 min to determine 
chemical toxicity.  As the concentration of doxycycline increased there was no change in 
cell viability compared with the no treatment condition, whereas within 15 min the cells 
showed noticeable decreases in viability when exposed to increasing concentrations of 
formaldehyde (Fig. 7).  These data confirm that doxycycline is not toxic to the cells 
within the working concentrations of my experiments.        
 
3.2.2 MDCK stable CAREx8 cells produces detectible Flag-tagged CAREx8 after 4 h 
of exposure to doxycycline, however the cells revert back to their parental state once 
the doxycycline is removed.    
 Knowing that the doxycycline is not toxic to the MDCK stable cells, we then 
asked how long it takes to detect CAREx8 expression after exposure to doxycycline.  To 
answer this question, MDCK CAREx8 stable cells were induced with 100 ng/ml 
doxycycline and were permitted to express CAREx8 (Fig. 8).   The cells were then 
harvested at increasing time intervals. The lysates were analyzed via Western blot using 
an antibody specific for the flag sequence.  CAREx8 could be observed as early as 4 h 
after induction (Fig. 8).  Following in suit the amount of CAREx8 protein increased as 
doxycycline exposure time was increased. These data show that CAREx8 expression 
vector is sensitive to doxycycline induction and protein synthesis is detectible at 4 h.   
Just as the induction with doxycycline of the MDCK CAREx8 stable cells increased 
CAREx8 expression over time, the removal of doxycycline reverts the cells back to a 
parental state in which no Flag-tagged CAREx8 can be detected.  This was tested by 
inducing MDCK CAREx8 stable cells with 100 ng/ml doxycycline for 24h (Fig. 8.).  The
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Figure 7.  Experimental concentrations of doxycycline does not cause 
cytotoxicity.  MDCK stable cells were seeded in a 96-well plate and incubated 
either with no doxycycline (negative control), increasing concentrations of 
doxycycline [100, 200, 1000 ng/ml] for 24 h (experimental), or with 
formaldehyde [0.1*, 1*, 2* %] for 15 minutes (positive control), at 37°C.  Cell 
viability was assessed for four wells of cells per conditions by MTT assay.  Error 
bars indicate standard error of the mean (SEM). (* = P < 0.05; One-Way 
ANOVA; Dunnett’s Post Hoc Test). 
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Figure 8. Induction of MDCK stable CAR
Ex8
 cells produce detectible 
levels of Flag-tagged CAR
Ex8
 after 4 h of exposure to doxycycline, but 
revert back to parental state once doxycycline is removed.  MDCK 
cells stably expressing Flag-tagged CAR
Ex8
 under a doxycycline-
inducible promoter were seeded on a plastic 24-well dish in FBS tet (-) 
media.  Cells were induced with doxycycline at ~80% confluence.  A 
portion of the cells were then lysed at either 1, 4, 8*, 12*, 24* h post 
doxycycline induction.  The remaining potion of the cells were induced 
with doxycycline for 24 h.  The doxycycline was then removed and the 
cells were lysed at either 0*, 4*, 8*, 10, 12, and 24 h post doxycycline 
removal.  Western blot analysis of the protein lysates was performed.  
The blots were then probed with rabbit anti-Flag antibody, followed by 
HRP-labeled anti-rabbit antibody, to determine the earliest time point in 
which Flag-CAR
Ex8
 could be detected, and if the expression was in fact 
time dependent and transient. (* = P < 0.05; One-Way ANOVA; Tukey’s 
Post Hoc Test).       
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doxycycline media was removed and replaced with standard FBS tet (-) culture media.  
The cells were harvested at increasing time points over the course of 24 h.  The lysates 
were then analyzed via Western blot.  The results show that the induced CAREx8 protein 
degraded in a time dependent fashion where no CAREx8 could be detected after 24 h, thus 
reverting the stable cells back to their parental state.  This again confirms that the CAREx8 
stable expression vector is sensitive to the presence of doxycycline. Also, it hinted at the 
rate of CAREx8 protein decay.  This led to my next hypothesis that these MDCK stable 
cell lines could be used to determine CAREx7 and CAREx8 half-lives.  
  
3.2.3 Experimental rational, structure, and design. 
 As shown previously, the CAREx8 expression vector is highly sensitive to 
doxycycline exposure and shows no signs of the vector being leaky.  I proposed that the 
MDCK stable cells lines are ideal model cell lines to study CAR protein turnover in. 
Optimal conditions and time frames were determined for said experiments and are 
modeled in (Fig. 5).   
 
3.2.4 Removal of doxycycline shows a time dependent degradation of induced 
proteins. 
 It was hypothesized that the MDCK stable cells could be used to monitor 
protein degradation over time.  Using a pulse chase structured experimental design, the 
stable cells were induced with 100 ng/ml doxycycline for 24 h to allow for protein 
expression.  The doxycycline was then removed and replaced with standard tet (-) culture 
media.  The cells were then harvested at increasing time intervals; the lysates were 
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analyzed via Western blot.  What was observed was that both CAREx7 and CAREx8 
showed similar patterns of time dependent degradation over the course of 24 h.    
 
3.2.4.1 CAREx8 degrades rapidly after doxycycline removal producing a short half-
life.   
 CAREx8 serves as the low abundance isoform of CAR.  Here we show that 
overexpressed CAREx8 degrades rapidly and is undetectable by 24 h once expression has 
stopped by removing doxycycline (Fig. 9).  However when viewing the Western blot, the 
CAREx8 protein appears to maintain a stable concentration until 8 h after doxycycline 
removal.  After 8 h hours the protein concentration decreases rapidly declining by half by 
10 h after dox removal.  CAREx8 decreases again by another half from 10 h to 12 h and is 
undetectable by 24 h.  From these data, the Western blot bands were quantified and 
normalized so that the half-life of CAREx8 could be calculated.  From these results it was 
determined that the half-life of CAREx8 is short, residing at 2 h.  The data show a plateau 
followed by one phase decay.  The cause for the stagnant plateau could be caused by 
many different factors such as the protein being more stable at higher concentrations, 
residual mRNA from the induced vector thus leading to continued protein synthesis, 
residual dox inducing the promoter, or the protein may be in complex with other proteins 
which might stabilize it, or the half-life rate is contingent on the concentration of protein 
which would produce a varying half-life.          
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Figure 9. CAR
Ex8
 degrades rapidly after doxycycline removal. A. MDCK cells 
stably expressing Flag-tagged CAR
Ex8
 under a doxycycline promoter were seeded in 
a plastic 12-well dish in FBS tet (-) media.  Cells were induced with 100 ng/ml 
doxycycline for 24 h.  The doxycycline containing media was then removed and 
replaced with standard FBS tet (-) culture media.  The cells were lysed at either 0 h 
(immediately), 4 h, 6 h, 8 h, 10 h, 12 h, and 24 h hours post doxycycline removal.  
Western blot analysis of the protein lysates was performed. Representative Western 
blots for CAR
Ex8
 (anti-Flag) and actin (loading control). B. Western blot bands were 
quantified using ImageJ software. CAR
Ex8
 bands were normalized to their 
corresponding actin bands.  These values were plotted in GraphPad Prism using a 
plateau followed by a one-phase exponential decay from which the half-life value 
was calculated. Error bars represent SEM. (* = P < 0.05; One-Way ANOVA; Tukey’s 
Post Hoc Test).       
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3.2.4.2 CAREx7 degrades after doxycycline removal producing a short half-life.   
 CAREx7 is the high abundance isoform of CAR.  Here we show that 
overexpressed CAREx7 degrades rapidly and is undetectable by 24 h once expression has 
stopped by removal of doxycycline (Fig. 10).  However when viewing the Western blot, 
the CAREx7 protein appears to maintain a stable concentration until 4 h after doxycycline 
removal.  After 4 h hours the protein concentration decreases steadily declining by half 
by 10 h after dox removal.  CAREx7 decreases again by another half from 10 h to 16 h and 
is undetectable by 24 h.  From these data, the Western blot bands were quantified and 
normalized so that the half-life of CAREx7 could be calculated.  From these results it was 
determined that the half-life of CAREx7 is relatively short, residing at 5.1 h.  The data 
show a plateau followed by two phase decay.  As with CAREx8, the cause for the stagnant 
plateau could be caused by many different factors such as the protein being more stable at 
higher concentrations, residual mRNA from the induced vector thus leading to continued 
protein synthesis, residual dox inducing the promoter, or the protein may be in complex 
with other proteins which might stabilize it, or the half-life rate is contingent on the 
concentration of protein which would produce a varying half-life.          
 
3.2.4.3 MDCK mCherry stable cells were used as a control to analyze “leaky 
expression” and Flag-antibody specificity.     
 MDCK stable mCherry cells were used as a control to first test if the Flag-tag 
antibody has any nonspecific binding within MDCK cell lysates, as well as to test the 
efficacy of the promoter and the potency of the doxycycline.  Here I show that the Flag 
antibody used produces no non-specific bands upon Western blot of lysates of stable cells
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Figure 10. CAR
Ex7
 degrades at a slower rate than CAR
Ex8
 after doxycycline 
removal. A. MDCK Cells stably expressing Flag-tagged CAR
Ex7 
under a doxycycline-
inducible promoter were seeded in a plastic 12-well dish in FBS tet (-) media.  Cells 
were induced with 100 ng/ml doxycycline for 24 h.  The doxycycline containing media 
was then removed and replaced with standard FBS tet (-) culture media.  The cells were 
lysed at either 0 h (immediately), 4 h, 6 h, 8 h, 10 h, 12 h, and 24 h hours post 
doxycycline removal.  Western blot analysis of the protein lysates was performed.  The 
blots were then probed with rabbit anti-Flag antibody to determine the rate at which 
Flag-CAR
Ex7
 degraded. Representative Western blots for CAR
Ex7
 and actin (loading 
control) are shown.  B. Western blot bands were quantified using ImageJ software. 
CAR
Ex7
 bands were normalized to their corresponding actin bands.  These values were 
plotted in GraphPad Prism using a plateau followed by a one-phase exponential decay 
in which the half-life value was calculated. Error bars represent SEM. (* = P < 0.05; 
One-Way ANOVA; Tukey’s Post Hoc Test). 
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 (Fig. 11). I also wanted to test if mCherry protein remains stable within the cell once the 
doxycycline is removed. Fluorescence images suggest that there is some red cells 
remaining 24 h after doxycycline is removed. Although half-life was not calculated, the 
length of detectable fluorescence suggests a half-life longer than CAREx8 or CAREx7. 
 
3.2.5 CAREx8 degrades rapidly at the apical surface of polarized epithelia after 
doxycycline removal producing a short half-life.   
 As the primary adenovirus receptor, CAREx8 at the apical surface is arguably 
of greatest concern to health.  Above I show that overexpressed CAREx8 degrades rapidly 
with a half-life of 2 h (Fig. 9).  However, since CAREx8 localizes apically in polarized 
epithelium, I then asked what is the rate of CAREx8 turnover at the apical surface.  I 
hypothesized that CAREx8 will maintain an even shorter half-life than total CAREx8 when 
localized at the apical surface.  To test this hypothesis, I used polarized MDCK CAREx8 
stable cells and induced them with 100 ng/ml doxycycline at increasing times over the 
course of 24 h, then let each condition express for 24 h.  The doxycycline was then 
removed for increasing time points over the course of 24 h and replaced with standard tet 
(-) culture media.  Once the last time point had been met, surface biotinylation was 
performed and the biotinylated proteins were isolated with streptavidin beads and 
analyzed via Western blot.  When viewing the Western blot, the CAREx8 protein appears 
to slightly stable for the initial 4 h after doxycycline removal but then decreases to 
undetectable over 24 h (Fig. 12).  At 8 h hours post doxycycline removal CAREx8 protein 
appears to have decreased to nearly 25% of its original concentration.  From these data, 
the Western blot bands were quantified and normalized so that the half-life of CAREx8
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Figure 11.  MDCK mCherry stable cells do not show “leaky expression” and 
demonstrate Flag-antibody specificity.  A. MDCK Cells stably expressing mCherry 
under a doxycycline-inducible promoter were seeded in a plastic 12-well dish in FBS 
tet (-) media. Cells were induced with 100 ng/ml doxycycline for 24 h.  The 
doxycycline containing media was then removed and replaced with standard FBS tet 
(-) culture media.  The cells were imaged and then lysed at either 0 h (immediately), 4 
h, 6 h, 8 h, 10 h, 12 h, and 24 h hours post doxycycline removal.  Western blot 
analysis of the protein lysates was performed.  The blots were then probed with rabbit 
anti-Flag antibody to test specificity of the antibody. Representative blots for Flag-
tagged proteins and actin (loading control) are shown B. Fluorescent images of 
mCherry (4X lens on a Nikon fluorescence microscope) over the course of 28 h post 
Dox removal shows that mCherry exhibits time dependent decay.  ((Fluorescent 
images 0*,4*,8* h (* = P < 0.05; One-Way ANOVA; Tukey’s Post Hoc Test)). 
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Figure 12. CAR
Ex8
 degrades rapidly at the apical surface of polarized 
epithelia.  A. MDCK Cells stably expressing CAR
Ex8
 under a doxycycline-
inducible promoter were seeded in a plastic 12-well dish in FBS tet (-) media. Over 
a course of 24 h the cells were induced at different time points with 100 ng/ml 
doxycycline.  Once each condition had been induced for 24 h, the doxycycline-
containing media was then removed at increasing time points over a course of 24 h 
and replaced with standard FBS tet (-) culture media.  At the last time point the 
cells were then chilled on ice where surface biotinylation was then performed. 
Cells were lysed and lysates (actin) or isolated-biotinylated proteins (CAR
Ex8
; Flag 
Ab) were then analyzed via Western blot. B. Western blot bands were quantified 
using ImageJ software.  CAR
Ex7
 bands were normalized to their corresponding 
actin bands.  These values were plotted in GraphPad Prism using a plateau 
followed by a one-phase exponential decay from which the half-life value was 
calculated. (* = P < 0.05; One-Way ANOVA; Tukey’s Post Hoc Test). 
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could be calculated.  From these results it was determined that the half-life of CAREx8 is 
short, residing at 1.8 h.  
 
3.2.6 CAR half-life is unchanged upon treatment with cycloheximide. 
 From the previous data, it can be seen that the half-life curves contained a 
plateau followed by a one-phase decay.  The plateau principle is applied to biological 
systems when a drug is being administered continuously or at steady intervals which can 
affect cellular functions.  It also applies to endogenous cases such as protein abundance 
in response to a hormone.  In our case, our cells were exposed to a continuous amount of 
doxycycline for a 24 h time frame.  The doxycycline was removed, and protein levels 
were assessed at increasing time points.  However, the doxycycline induces the 
expression of mRNA transcripts.  Once the doxycycline is removed, the mRNA 
transcripts that were expressed are still able to be translated until they too are degraded.  
Thus, we hypothesized that the plateau effect was caused by residual mRNA being 
translated even after doxycycline was removal.  To test this hypothesis, we used the same 
experimental protocol as demonstrated in (Fig. 5), however, once the doxycycline was 
removed, the cells were replenished with standard tet (-) culture media supplemented 
with cycloheximide (CHX), a protein synthesis inhibitor, to inhibit translation of nascent 
proteins.  If the plateau was in fact due to the translation of residual mRNA, then the 
cycloheximide should block this process, and the new curves should yield more accurate 
protein half-life values.   
 
 
	  42	  
3.2.6.1 CAREx8 half-life is unchanged upon treatment with cycloheximide.  
 In theory, if the CAREx8 half-life observed in (Fig. 9) is accurate, then the 
addition of cycloheximide will only serve to eliminate the plateau; however the half-life 
should remain relatively the same. To test this hypothesis, the MDCK stable CAREx8 cells 
were treated with doxycycline for 24h.  The doxycycline was then removed and replaced 
with standard tet (-) culture media containing cycloheximide, a protein synthesis inhibitor 
and lysed at increasing time points.  As hypothesized, the addition of cycloheximide did 
in fact substantially reduce the large plateau initially seen in (Fig. 9) to nearly a non-
existent plateau (Fig. 13).  Again, corroborating with the hypothesis, the half-life of 
CAREx8 remained the same at 2.0 h.     
              
3.2.6.2 CAREx7 half-life is increased upon treatment with cycloheximide.  
 As aforementioned, in theory, if the CAREx7 half-life observed in (Fig. 10) is 
accurate, then the addition of cycloheximide will only serve to eliminate the plateau, 
however the half-life should remain relatively the same. To test if CAREx7 half-life is 
changed by the addition of cycloheximide, the MDCK stable CAREx7 cells were treated 
with doxycycline for 24 h.  The doxycycline was then removed and replaced with 
standard tet (-) culture media containing cycloheximide, a protein synthesis inhibitor and 
lysed at increasing time points.  Here we show that the estimated half-life for CAREx7 is 
5.3 h (Fig. 14) which is consistent with the above reported half-life of 5.1 h.     
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Figure 13. Cycloheximide effectively reduces the plateau phase during 
CAR
Ex8
 degradation, but still produces the same half-life.  A. MDCK Cells 
stably expressing Flag-tagged CAR
Ex8
 under a doxycycline-inducible promoter 
were seeded in a plastic 12-well dish in FBS tet (-) media.  Cells were induced 
with 100 ng/ml doxycycline for 24 h.  The doxycycline containing media was then 
removed and replaced with standard FBS tet (-) culture media supplemented with 
30 µg/ml cycloheximide (a protein synthesis inhibitor).  The cells were lysed at 
either 0 h (immediately), 4 h, 6 h, 8 h, and 10 h post doxycycline removal.  
Western blot analysis of the protein lysates was performed.  The blots were then 
probed with rabbit anti-Flag antibody to determine the rate at which Flag-CAR
Ex8
 
degraded.  Representative CAR
Ex8
 and actin (loading control) Western blots are 
shown. B. Western blot bands were quantified using ImageJ software.  CAR
Ex8
 
bands were normalized to their corresponding actin bands.  These values were 
plotted in GraphPad Prism using a plateau followed by a one-phase exponential 
decay from which the half-life value was calculated. (* = P < 0.05; One-Way 
ANOVA; Tukey’s Post Hoc Test). 
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Figure 14. Cycloheximide reduced the plateau phase of CAR
Ex7
 degradation and 
does not significantly alter CAR
Ex7
 half-life.  A. MDCK Cells stably expressing 
Flag-tagged CAR
Ex7 
under a doxycycline-inducible promoter were seeded in a plastic 
12-well dish in FBS tet (-) media.  Cells were induced with 100 ng/ml doxycycline 
for 24 h.  The doxycycline containing media was then removed and replaced with 
standard FBS tet (-) culture media supplemented with 30 µg/ml cycloheximide (a 
protein synthesis inhibitor).  The cells were lysed at either 0 h (immediately), 4 h, 6 
h, 8 h, and 10 h post doxycycline removal.  Western blot analysis of the protein 
lysates was performed.  The blots were then probed with rabbit anti-Flag antibody to 
determine the rate at which Flag-CAR
Ex7
 degraded.  Representative CAR
Ex7
 and actin 
(loading control) Western blots are shown. B. Western blot bands were quantified 
using ImageJ software.  CAR
Ex7
 bands were normalized to their corresponding actin 
bands.  These values were plotted in GraphPad Prism using a plateau followed by a 
one-phase exponential decay from which the half-life value was calculated. (* = P < 
0.05; One-Way ANOVA; Tukey’s Post Hoc Test). 
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3.2.7 Endogenous CAREx8 and total-CAR half-lives yield a steady rate of decay in 
CaLu-3 cells.  
 Our lab is interested in how CAR is being regulated in polarized human 
airway epithelial.  However, in the previous studies, CAR half-life was being determined 
using an inducible MDCK stable cell line, thus all the CAREx7 and CAREx8 were both 
over expressed and Flag-tagged at the N-terminus.  Four major limitations are presented 
in these experiments i.) these cell lines are canine kidney cells although the CAR gene 
within the integrated inducible vector being expressed is human and thus may not be 
recognized or degraded at the same rate as endogenous CAR; ii.) over expression of these  
proteins may overwhelm the cells regulation machinery; iii.) residual mRNA from 
overexpression allows for nascent protein translation once doxycycline induction has 
stopped, possibly altering the time frame of degradation; and iv.) the Flag-tag on the 
proteins may disturb or alter the rate of protein degradation.  To address these limitations, 
CAR half-life was observed in CaLu-3 cells, a highly-studied human lung cell line able to 
polarize into an epithelium.  This was done by treating CaLu-3 cells with cycloheximide 
for different lengths of time, then lysing the cells and determining the concentration of 
CAREx8 and total-CAR at increasing time points (Fig. 15).  Interestingly, the calculated 
half-lives of both CAREx8 and total CAR were roughly the same as initial experiments 
performed in the MDCK stable cell lines, with half-lives at 2.4h (CAREx8) and 4.5h 
(total-CAR; a combination of both CAREx7 and CAREx8) when plotted with a plateau 
followed by a one phase decay.  
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Figure 15. Endogenous CAR
Ex8 
and total-CAR half-lives are relatively short in 
CaLu-3 cells.  A.  CaLu-3 cells were treated with 30 µg/ml cycloheximide (a protein 
synthesis inhibitor).  The cells were lysed at either 0 h (immediately), 1 h, 2 h, 4 h, 8 
h, and 24 h post cycloheximide addition.  Western blot analysis of the protein lysates 
was performed.  The Western blots were then probed with rabbit-5678 (CAR
Ex8 
specific antibody) or rabbit-1605 (Total-CAR antibody), and anti-actin (loading 
control). B. Western blot bands were quantified using ImageJ software.  CAR
Ex8
 and 
total-CAR bands were normalized to their corresponding actin bands.  These values 
were plotted in GraphPad Prism using a plateau followed by a one-phase exponential 
decay from which the half-life value was calculated. (* = P < 0.05; One-Way 
ANOVA; Tukey’s Post Hoc Test). 
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3.2.8 Adenovirus transduction decreases as CAREx8 degrades but remains 
unaffected with CAREx7 degradation.   
 Induction of MDCK CAREx7 and CAREx8 stable cells with doxycycline 
increases the expression of either CAREx7 or CAREx8 (Fig. 4).  Correspondingly, 
adenovirus infection of these polarized cell lines increases most when CAREx8, the apical 
surface isoform of CAR, is overexpressed and not upon overexpression of CAREx7, the 
isoform sequestered on the basolateral surface of the polarized cells (data not shown) [9].  
The removal of doxycycline reverts the cells back to a parental state in which no Flag-
tagged CAR can be detected (Fig. 9A; Fig. 10A).  It was then asked if the degradation of 
these proteins affects adenoviral infection.  This was tested by inducing the polarized 
MDCK CAREx7 or CAREx8 stable cells with 100 ng/ml doxycycline for 24 h.  The 
doxycycline media was removed at increasing time intervals (0 h – 24 h) and replaced 
with standard culture media.  Once each time point had been met, the cells were 
transduced with recombinant adenovirus carrying the β-galactosidase reporter gene (MOI 
100) for 1 h. β-galactosidase activity was analyzed 24 h later. The results showed that as 
the induced CAREx8 protein degraded there was a direct correlation with a decrease in β-
galactosidase activity (Fig. 16A; p<0.05).  Conversely as the induced CAREx7 protein 
degraded, there was little to no change in β-galactosidase activity (Fig. 16B).  These data 
further confirm that CAREx8 not only localizes at the apical surface of polarized epithelia 
but also acts as the primary receptor for adenoviruses.  
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Figure 16. Adenovirus transduction decreases as CAR
Ex8
 degrades but remains 
unaffected with CAR
Ex7
 degradation.  MDCK Cells stably expressing Flag-
tagged A. CAR
Ex8; 
or B. CAR
Ex7
 under a doxycycline-inducible promoter were 
seeded in a plastic 24-well dish in FBS tet (-) media.  Over a course of 24 h the cells 
were induced at different time points with 100 ng/ml doxycycline.  Once each 
condition had been induced for 24 h, the doxycycline containing media was then 
removed at increasing time points over a course of 24 h and replaced with standard 
FBS tet (-) culture media.  At the last time point the cells were then transduced with 
AdV-β-Gal (MOI 100) for 1 h. β-Gal activity was assessed from four wells of cells 
per condition 24 h later by β-galactosidase assay.  Error bars indicate standard error 
of the mean (SEM). (A.* = P < 0.05; One-Way ANOVA; Tukey’s Post Hoc Test). 
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3.3 Conclusion 
 Due to the nature in which the proteins degraded, it was hypothesized that the 
half-life of both CAREx7 and CAREx8 could be calculated from the Western blots.  First, 
ImageJ software was used to quantify the band density of the proteins of interest (CAREx7 
or CAREx8).  The corresponding band density for actin (a house keeping gene) was also 
quantified.  The band values of the proteins of interest (CAREx7 or CAREx8) were 
normalized to their corresponding actin band values. Next, these values were plotted in 
Prism, GraphPad on either a plateau followed by a one-phase exponential decay plot, or a 
standard first ordered one phase exponential decay plot  where program software 
generated standard error of the mean (SEM), an R2 value, and the relative half-lives by 
way of (eq. 1) for the proteins of interest.  From these studies the half-lives of CAREx7, 
CAREx8, apical turnover of CAREx8, and total-CAR were calculated (Table 2). 
 Based on the above, data it is clear that the MDCK stable cell lines were 
appropriate models for studying CAREx7 and CAREx8 protein expression and degradation. 
We also saw that it takes approximately 4h for the induced protein to be detected by 
Western blot when using 100 ng/ml doxycycline.  Next we showed that once doxycycline 
is removed, cells revert back to a parental state, as the induced proteins are degraded in a  
 short time frame.  From these data, it was hypothesized that the estimated half-lives for 
CAREx7 and CAREx8 could be calculated.  I further confirmed this hypothesis by showing 
that CAREx7 has an estimated half-life of ~5.1 h while CAREx8 has an estimated half-life 
of ~2 h.  The apical turnover rate of CAREx8 is slightly faster than the total half-life of 
CAREx8 at ~1.8 h using a plateau followed by a one phase decay.  To address the 
presence of the plateau seen in all of the Western blots and half-life graphs, I 
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Table 2.  Half-life of CAR isoforms. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cell Line CAR Isoform Cycloheximide Half-life (h) 
MDCK CAREx8 
Stable 
CAREx8 - 2.0 ± 1.4 
MDCK CAREx7 
Stable 
CAREx7 - 5.1 ± 0.6 
MDCK CAREx8 
Stable 
Apical-CAREx8 - 1.8 ±  1.9 
MDCK CAREx8 
Stable 
CAREx8 + 2.0 ± 1.5 
MDCK CAREx7 
Stable 
CAREx7 + 5.3 ± 1.5 
CaLu-3 CAREx8 + 2.4 ± 0.05 
CaLu-3 Total-CAR + 4.5 ± 0.02 
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hypothesized that the plateau was caused by residual mRNA from the induced vector 
once the doxycycline was removed.  To test this, the same experiments were performed 
in the presence of cycloheximide (a protein synthesis inhibitor) in order to prevent further 
translation of existing mRNA.  Interestingly enough, the data obtained showed a 
substantial reduction in the plateau time but yielded nearly the same half-life values as 
the initial experiments with 2 h and 5.3 h for CAREx8 and CAREx7 respectively.   
 We then asked if endogenous CAREx8 in CaLu-3 cells shows the same trend in 
degradation and maintains a similar half-life as calculated earlier in the MDCK stable 
cells.  This was addressed by inhibiting protein synthesis in CaLu-3 cells with 
cycloheximide then lysing the cells at increasing time points.  Here we show that  
endogenous CAREx8 decays at a slightly slower rate with a half-life of 2.4 h as compared 
to the over expressed CAREx8 in the MDCK stable cells. Total CAR had a slightly shorter 
half-life of 4.8 h that CAREx7 alone. This is possibly due to the presence of both isoforms 
within the Western blot bands. 
 Lastly, to further confirm the ability for CAREx8 to act as the primary receptor 
for adenoviruses in polarized epithelia, we show that as CAREx8 degraded in the MDCK 
cells, there was a corresponding decrease in adenovirus transduction.  However this same 
trend was not seen with the MDCK cells overexpressing CAREx7.  This shows that the 
apical isoform of CAR, CAREx8, is responsible for initiating adenovirus infection from 
the apical surface, while the basolateral isoform of CAR, CAREx7, is sequestered beneath 
the tight junctions and is inaccessible for adenovirus transduction.   
 Protein half-lives differ from protein to protein.  In mammalian cells the 
global median protein half-life is ~46 h [38].  Localization of a protein within a polarized 
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epithelium may play a significant role in a proteins half-life.  Apical proteins have been 
shown to have half –lives ranging from ~1h to ~24h and global analysis conferred that 
plasma membrane proteins can have half-lives <100h or shorter half-lives >4h [39-42].  
Protein degradation is usually a first order reaction, thus the half-lives were analyzed 
using a plateau followed by a one-phase exponential decay [33, 43].  
 The limitation within the experimental designs lay with the conditional parameter 
such as the use of cycloheximide. In that, cycloheximide does not inhibit 100% of protein 
synthesis, but rather it only blocks 70-80% of protein synthesis, and takes a minimum of 
15 min exposure to be effective therefore, there still may be nascent protein translation 
and thus the calculated values for the varying isoforms of CAR may not be true 
representations of protein decay.  In the future, these experiments should be repeated with 
more time points at shorter intervals, and either a higher concentration of cycloheximide, 
or a different protein synthesis inhibitor such as emetine, or by radioactively labeling 
newly synthesized proteins [44, 45]. 
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Chapter 4. Src-family kinases role in the expression of the coxsackievirus and 
adenovirus receptor and adenovirus infection. 
4.1  Rationale 
 Since CAR is tightly regulated, as shown by the relatively short half-life (Table 
2.), I then asked what protein interactions are involved in the regulation of CAR.  Here I 
focused my studies on the role of the Src-family kinases in the expression of CAR and 
adenovirus infection. 
 Cell signaling plays an important role in viral infection.  After a virus attaches to 
its primary receptor, a signaling cascade is set in motion in order for the virus to be 
internalized by the cell. Further signaling is required to successfully traffic the virus to its 
site of replication.  Kinases play a large part in these signaling cascades.  Previous studies 
have shown that Src-family kinase inhibition decreased adenoviral infection in airway 
epithelia [21].  The reduced infection was attributed to the mislocalization of integrins to 
the basolateral surface of the polarized epithelium.  However, CAR has several putative 
phosphorylation sites at its C-terminus, which are potential locations for phosphorylation 
by Src-family kinases.  These potential interactions led to the hypothesis that Src-family 
kinases alter adenoviral entry by regulating the expression of CAREx8.  To test this 
hypothesis, CaLu-3 cells were treated with various Src-family kinase inhibitors and 
analyzed for viral entry and transduction, as well as CAREx8 expression. 
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4.2 Results 
4.2.1 Optimizing CaLu-3 cell culture and experimental conditions.   
 CaLu-3 cells are a polarizing epithelial lung cell line.  As mentioned earlier, 
polarized epithelia are highly resistant to viral infection unless there is abundant CAREx8 
at the apical surface. CaLu-3 cells are able to form a well differentiated polarized 
monolayer, however, they also exhibit odd growth patterns in that they can grow in dense 
clumps, or, once polarized, they begin to grow on top of each other.  If the cells are 
seeded too low, they tend to not grow, but if seeded too high, they grow into a multilayer 
cell sheet.  Initially when performing experiments, the data were not reproducible 
because the cells would not grow the same every time.  In order to optimize experimental 
conditions with CaLu-3 cells, a series of experiments were performed to determine 
appropriate cell seeding density, and efficient growth period for the cells so that 
experimental conditions would be the same throughout the studies so that results would 
be consistent and reproducible.    
 
4.2.1.1 CaLu-3 cell seeding densities. 
 First, the cell seeding density of the CaLu-3 cells was addressed.  Standard 
protocol suggests that CaLu-3 cells should be seeded at 2.5x105 in order to obtain a ~80% 
confluence by the next day.  However, it may take longer for cells to completely polarize 
and form proper tight junctions. Also, most of the experiments performed require a 
longer time frame for different treatment variables and viral infection.  To examine the 
most relevant cell seeding density, CaLu-3 cells were seeded on a 24 well dish at 
increasing densities (1, 1.5, 2, 2.5 (x105)) of cells per well.  The cells were then allowed 
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Figure 17. CaLu-3 optimal cell seeding density.  CaLu-3 cells were seeded at 
increasing cell densities on a 24-well plate.  The cells were allowed to adhere and 
grow for 48 h post seeding.  Each condition was imaged at either A.  the edge of 
the well; or B.  the center of the well to determine relative confluence (10X lens on 
a Nikon fluorescence microscope using bright field microscopy).      
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to adhere and grow for 48 h and then observed for relative densities under 10 x bright 
field microscopy (Fig. 17).  From the images, it can be seen that when seeded at 1x105, 
the CaLu-3 cells grew in dense clumps, while at 2x105 and 2.5x105 grew very dense in 
the center of the well.  However, when seeded at 1.5x105, the cells appeared healthier at 
the center of the well, and cell borders were visible, with no over growth or growing on 
top of each other.  From these data, to optimal seeding density was determined to be 
1.5x105 cells per well. 
        
4.2.1.2 CaLu-3 cells take several days to polarize. 
 Next, I examined CaLu-3 growth period in order to determine the time needed to 
establish a polarized monolayer.  This was done by seeding CaLu-3 cells at 1.5x105 cells 
per well on a 24 well dish, as determined was optimal in the previous study, and allowed 
to grow for increasing time frames (24 h, 48 h, 72 h, 96 h).  Then using AdV-GFP as a 
surrogate marker for cell polarity, the cells were transduced with AdV-GFP for 1 h at an 
MOI of 100 after the allotted growth period. GFP expression was analyzed 24 h later 
using 10 x fluorescent microscopy (Fig. 18).  Here we see that the cells were only 
successfully infected at the periphery of the monolayers or at the cell islands.  The cells 
transduced at 24 h and 48 h post seeding show the most GFP expression, while 72 h, and 
96 h show the least.  However, the 96 h condition showed the most confluent monolayer. 
Thus, allowing the cells to grow for 96 h before transduction would yield the best 
polarized monolayer without allowing the cells to over grow. 
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Figure 18. CaLu-3 optimal growth period to form a polarized monolayer.  
CaLu-3 cells were seeded at 1.5x10
5
 on a 24-well plate.  The cells were then 
transduced with AdV-GFP (MOI 100) either 24 h, 48 h, 72 h, or 96 h after seeding.  
The cells were observed 24 h later for GFP expression (10X lens on a Nikon 
fluorescence microscope).  Each condition was imaged at either A. the edge of the 
well; or B. the center of the well to determine relative confluence, polarity, and 
AdV-GFP-mediated GFP fluorescence.    
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4.2.1.3 Optimal conditions for experiments performed on CaLu-3 cells.  
 From the previous two studies, it was determined that the optimal cell seeding 
density for CaLu-3 cells is 1.5x105 with a growth period of 96 h before adenovirus 
transduction on a 24 well plate.  These results show the ideal conditions for CaLu-3 cells 
that yields a polarized monolayer of cells for conduction of experiments that produces 
consistent and repeatable results (Fig. 19). However, even on larger tissue culture plates, 
the CaLu-3 cells still pose the same difficulties in growth patterns.  Thus, a similar set of 
experiments were performed to determine optimal conditions for CaLu-3 cell seeding 
density and growth period on 6 well plates.  These conditions favored 2.5x105 cells per 
well with 96 h growth period to obtain consistent results (data not shown).  
 
4.2.2 Inhibiting Src-family kinases decreases adenovirus infection. 
 To confirm that inhibition of Src-family kinases decreases the adenoviral 
infection of polarized epithelia, CaLu-3 cells, a model polarizing human lung cell line, 
were treated with either DMSO (vehicle control) or increasing doses of one of the 
following small molecule inhibitors for Src-family kinases, PP1 or PP2, for 1h.  The 
treated cells were then infected with adenovirus carrying the β-galactosidase reporter 
gene (MOI 100) for 1 h, then washed and replenished with standard culture media 
containing the chemical inhibitor.  The cells were analyzed 24 h later via a β-
galactosidase assay.  As expected, the CaLu-3 cells showed a remarkable dose dependent 
resistance to adenovirus infection upon treatment with the chemical inhibitors (Fig. 20; 
p<0.001).  From these data, the working concentration of PP2 was determined to be 5 
µM.  This was because 5 µM PP2 showed a similar decrease in viral infection (65%) as 
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Figure 19. CaLu-3 optimal seeding density and growth period to form a 
polarized monolayer.  CaLu-3 cells were seeded at 1.5x10
5
 on a 24-well plate and 
allowed to polarize for 96 h.  The cells were then transduced with AdV-GFP (MOI 
100) and imaged for GFP expression 24 h later (10X lens on a Nikon fluorescence 
microscope). Each condition was imaged at either A. the center of the well; or B. 
the edge of the well to determine relative confluence and polarity.    
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Figure 20. Inhibiting Src-family kinases decreases adenoviral transduction.  
CaLu-3 cells were treated with Src-family kinase inhibitor A. PP1; or B. PP2 
(small molecule inhibitors specific for Src-family kinases) for 1 h then transduced 
with AdV-β-Gal  (MOI 100) for 1 h. Cells were washed and replenished with 
standard growth media containing chemical inhibitor over night. β-galactosidase 
assay was performed 24 h later after transduction. β-Gal activity was assessed for 
four wells of cells per condition by β-galactosidase assay.  Error bars indicate 
standard error of the mean (SEM). (* = P < 0.05; One-Way ANOVA; Tukey’s Post 
Hoc Test). 
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10 µM PP2 (70%).  The lower concentration ensures less toxicity to the cells, as well as 
less chance for off-target effects.  Additionally, 5 µM PP2 has been shown to be an 
effective concentration able to decrease other viral infections, such as decreasing reovirus 
infection by 70% [32].  PP1 was not used to test any further viral infection assays 
because the lowest dose that yielded a significant decrease in adenoviral infection was 
100 µM.  Thus, PP1 showed less specificity and has a higher potential to be toxic to the 
cells or cause off-target effects.   
 
4.2.3 PP2 inhibits adenovirus infection at an early stage in infection.  
 Since inhibiting Src-family kinases resulted in a significant decrease in adenoviral 
infection I asked at what time point after adenovirus binding does Src-family kinase 
inhibition decreases viral infection. Based on the findings with reovirus, which shows an 
effect at early stages of infection [32], I hypothesized that Src family kinases play a 
crucial role in adenoviral trafficking at an early time point.  To test this hypothesis, 
CaLu-3 cells were treated with PP2 [5 µM], or DMSO as a control, for 1 h before (pre), 
during, immediately after (post), or 1 h after (post) AdV-β-gal infection (Fig. 21; 
p<0.05).  Adenovirus transduction was analyzed 24 h later via a β-galactosidase assay.  
Adenoviral transduction showed a marked decrease in the immediate post-treated 
conditions. Whereas, the pre-treated and 1 h post treated cells showed a negligible 
decrease in transduction.  These data suggest that Src-family kinases play a crucial role in 
viral trafficking immediately post viral internalization.  It is predicted that inhibiting Src-
family kinases at an early time point in viral infection results in decreased viral 
trafficking to the nucleus and increased viral degradation. 
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Figure 21. Inhibiting Src-family kinases with PP2 decreases adenoviral 
transduction at an early point in viral entry.  CaLu-3 cells treated with PP2 [5 
µM]  at different time points relative to adenovirus infection: either before, during, 
or after transduction with AdV-β-Gal  (MOI 100; 1 h).  β-Gal activity was assessed 
for four wells of cells per condition 24 h later by β-galactosidase assay.  Error bars 
indicate standard error of the mean (SEM). (* = P < 0.05; One-Way ANOVA; 
Tukey’s Post Hoc Test). 
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4.2.4 Inhibiting Src-family kinases with PP2 for extended time frames decreases 
adenoviral genomes. 
 Initially, we showed that adenoviral transduction exhibited a dose dependent 
decrease when treated with the Src-family kinase inhibitor PP2 (Fig. 20).  I then 
investigated at what time does Src-family kinase inhibition with PP2 play a role in viral 
infection.  It was shown that PP2 acts at an early stage in viral infection, roughly within 
the first hour post infection.  However, viral infection decreased by only 30% (Fig. 21) 
whereas in dose response assay, viral infection decreased by 65% (Fig. 20).   We then 
hypothesized that extended Src-family kinase inhibition results in further decrease in 
viral transduction.  To test this hypothesis, CaLu-3 cells were treated with PP2 [5 µM] for 
8 h or 24 h then transduced with recombinant adenovirus (MOI 100) for 1 h then 
analyzed for viral genomes 24 h later (Fig. 22; p<0.0001).  In congruence with the 
hypothesis, inhibiting Src-family kinases for 8 h pre-adenovirus infection showed an 80% 
decrease in viral genomes, while 24 h inhibition reduced viral genomes to nearly zero.  
The significant decrease in viral genomes could be caused by several factors such as a 
decrease in i.) viral receptor (i.e. CAR mRNA, protein, or localization); ii.) viral 
trafficking to the nucleus; iii.) replication machinery; or iv.) off-site targets.       
 
4.2.5 Inhibiting Src-family kinases has no noticeable effect on CAREx8 at early time 
points.   
 To address the decrease seen in viral genomes with extended Src-family kinase 
inhibition, we hypothesized that inhibiting Src-family kinases for an extended time 
decreases CAREx8 abundance in epithelial cells. To test this hypothesis, CaLu-3 cells 
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Figure 22.  Inhibiting  Src-family  kinases  with  PP2  
for   extended   time   points   decreases   adenoviral  
genomes.      CaLu-3   cells   were   treated   with   PP2   [5  
μM]   for   8   h   or   24   h   then   transduced   with  
recombinant   adenovirus   (MOI   100)   for   1   h,   then  
DNA   isolated   from   total   lysates   were   analyzed   for  
viral  genomes  24  h  later.  qPCR  was  performed  24  h  
later.  Viral  genomes  were  quantified  for  four  wells  of  
cells   per   conditions   by   qPCR.      Error   bars   indicate  
standard  error  of  the  mean  (SEM);;  (p<0.0001). 
 
Figure 22. Inhibiting Src-family kinases with PP2 for extended time points 
decreases adenoviral genomes.  CaLu-3 cells were treated with PP2 [5 µM] 
for 8 h or 24 h then transduced with recombinant adenovirus (MOI 100) for 1 
h.  Then DNA isolated from total lysates was analyzed for viral genomes by 
qPCR 24 h later. Viral genomes were quantified for four wells of cells per 
condition.  Error bars indicate standard error of the mean (SEM). (* = P < 
0.0001; One-Way ANOVA; Tukey’s Post Hoc Test). 
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were treated with PP1 [0, 1, 10 µM] for 24 h or PP2 [5 µM] for increasing time points 
then harvested and analyzed via Western blot (Fig. 23).  In congruence with my 
hypothesis, CAREx8 expression did show a substantial decrease with extended exposure 
to PP2 but showed no change within the early time points of treatment (Fig. 23B).  Also, 
increasing concentrations of PP1 exhibited no effect on CAREx8 expression (Fig. 23A).  
Knowing that CAREx8 has a half-life of 2.4 h in CaLu-3 cells (Fig. 15), we predicted that 
if inhibiting Src-family kinases had a direct role in CARex8 protein expression, then we 
would expect to see a decrease in protein levels at the earlier time points.  However, this 
was not the case.  Thus, inhibiting Src-family kinases could have an indirect role in 
CAREx8 expression, or extended exposure to PP2 could have potential off target effects, 
or exhibit a degree of cytotoxicity.     
 
4.2.6 Src-family kinase inhibitor is not toxic to CaLu-3 cells.   
 To determine if PP2 is toxic to the cells, CaLu-3 cells were treated with 
increasing concentrations of PP2 for 24 h or formaldehyde for 15 min (positive control).  
Cell viability was determined using an MTT assay.  As the concentration of PP2 
increased there was no change in cell viability compared with the no treatment condition, 
whereas within 15 min the cells showed noticeable decreases in viability when exposed 
to increasing concentrations of formaldehyde (Fig. 24).    These data confirm that PP2 is 
not toxic to the cells within the working concentrations of my experiments, and further 
confirms that the decrease seen in CAREx8 expression and adenoviral genomes with 
extended exposure to PP2 is a result of indirect Src-family kinase regulation of CAREx8 
or off-target effects of the chemical inhibitor.      
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Figure 23. Inhibiting Src-family kinases does not change CAR
Ex8
 expression at early 
time points.  A. CaLu-3 cells were treated with PP1 [1 and 10 µM] or DMSO for 24 h 
then CAR
Ex8 
expression was analyzed by Western blot. B. CAR
Ex8
 band density relative 
to actin. C. CaLu-3 cells were treated with PP2 [5 µM] or DMSO for increasing times 
then CAR
Ex8 
expression was analyzed by Western blot. D. CAR
Ex8
 band density relative 
to actin.  
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Figure 24.  Experimental concentrations of PP2 and DMSO do not cause 
cytotoxicity.  CaLu-3 cells were seeded in a 96-well plate and incubated either with no 
PP2, negative control; PP2 [0.1, 1, 5, 10 µM] for 24 h, experimental; or with 
formaldehyde [0.1, 1, 2 %]* for 15 minutes, positive control; at 37°C.  Cell viability 
was assessed for four wells of cells per condition by MTT assay.  Error bars indicate 
standard error of the mean (SEM).  (* = P < 0.05; One-Way ANOVA; Dunnett’s Post 
Hoc Test). 
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4.2.7 Adenovirus activates c-Src kinase at early time points during infection.      
 Src-family kinases remain inactive within the cell by auto-phosphorylation at 
tyrosine 527 (Y527) (Fig. 25) [46, 47].  However, in response to stimuli, Src-family 
kinases are dephosphorylated at Y527 and become phosphorylated at tyrosine 416 
(Y416) rendering the kinase active (Fig. 25)[46].  Inhibiting Src-family kinases inhibits 
the kinases ability to be activated and thus leads to a significant decrease in adenoviral 
infection. This suggests that active Src-family kinases are required for efficient 
adenoviral infection.  I hypothesized that adenovirus infection activates Src-family 
kinases in order to promote viral infection.  To test this hypothesis, CaLu-3 cells were 
serum starved then adsorbed with adenovirus at 4°C for 1 h. The cells were washed and 
lysed at 0, 30, and 60 minutes after being placed back into the incubator at 37°C and 5% 
CO2. Whole cell lysates were then analyzed via Western blot (Fig. 26).  The results 
showed that c-Src kinase is activated at an early time point during adenovirus infection 
and decreases activity over the course of infection.  This suggests that c-Src kinase plays 
a role in infection by way of viral entry or trafficking.    
 
4.2.8 Activating Src-family kinases does not alter adenovirus infection or CAREx8 
expression. 
 Previously it was shown that inhibiting Src-family kinases decreases adenoviral 
infection while adenovirus infection activates c-Src kinase at an early stage in infection. 
This led me to hypothesize that increasing Src-family kinase activity would increase 
adenoviral infection.  To test this hypothesis, CaLu-3 cells were treated with DMSO or 
increasing concentrations of Src-family kinase activator (SC-3052) for 1 h, then infected 
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Figure 25. Model of Src-family kinases.  A. Linear model of protein structure.  
B. Phosphorylation dependent activation states of Src-family kinases.  
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Figure 26.  Adenovirus activates c-Src kinase.  A. CaLu-3 cells were seeded on a 6-
well plate and grown to ~80% confluence.  The cells were then chilled and treated with 
DMSO or adsorbed with adenovirus (MOI 1000) at 4°C for 1 h.  The cells were washed 
then placed back at 37°C.  The cells were then lysed at increasing time points, after 
DMSO or viral adsorption (as indicated above), with lysis buffer containing protease 
and phosphatase inhibitors.  Lysates were then analyzed by Western blot.  The blot was 
probed with rabbit-Phospho c-Src-Y416 (an antibody specific for active c-Src) or actin 
(a loading control).  B.  Phospho c-Src-Y416 band density relative to actin. 
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with recombinant AdV-β-gal (MOI 100) for 1 h in the presence of the activator (Fig. 
27A).  The cells were then washed and replenished with standard growth media and 
chemical activator, and analyzed for viral transduction 24 h later via a β-galactosidase 
assay.  The results show that as the concentration of Src activator increased, there was no 
significant change in adenoviral transduction.   
 Although viral transduction did not change with Src-family kinase activation, 
CAREx8 expression was still examined.  CaLu-3 cells were treated with Src activator for 
increasing time intervals then lysed and analyzed by Western blot.  In correlation with the 
β-galactosidase assay cells incubated with Src-family kinase activator showed no 
noticeable changes in CAREx8 expression (Fig. 27B).   
 
4.2.9 c-Src kinase is required for efficient adenovirus infection. 
 Since the Src family inhibitors used above may inhibit several proteins in the 
family, HeLa cells expressing shRNA for either c-Src kinase or a Scrambled shRNA 
were used to specifically examine the role of c-Src kinase in adenovirus infection, (Fig. 
28).  shHeLa cells were seeded and with AdV-β-Gal (MOI 100) for 1 h, washed, 
replenished with standard culture media and analyzed for β-gal activity 24 h later (Fig. 
28C; p<0.001).  It was observed that the cells expressing shRNA for c-Src kinase 
significantly decreased in viral transduction by 70%.  To confirm that c-Src kinase was 
knocked down, c-Src expression was analyzed via Western blot (Fig. 28A, B).  HeLa 
cells expressing shRNA for c-Src demonstrated a 50% reduction in c-Src kinase 
expression as compared to the HeLa-shRNA-Scramble control, indicating successful 
knockdown of c-Src Kinase.  
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Figure 27. Activating Src-family kinases does not affect adenoviral transduction 
or CAR
Ex8
 expression.  A. CaLu-3 cells treated with Src activator [0, 0.1, 1, 10, 100 
µM]  for 1 h then transduced with AdV-β-Gal  (MOI 100) for 1 h. Cells were washed 
and replenished with standard growth media. The cells were analyzed 24 h post 
infection for β-Gal activity for four wells of cells per condition by β-galactosidase 
assay.  Error bars indicate standard error of the mean (SEM). B. CaLu-3 cells were 
treated with Src activator [10 µM] or DMSO for increasing time points.  CAR
Ex8 
expression was analyzed by Western blot. (* = P < 0.05; One-Way ANOVA; Tukey’s 
Post Hoc Test).   
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Figure 28. c-Src shRNA decreases total c-Src kinase protein expression and 
adenoviral transduction but has no affect on CAR
Ex8
 expression.  A. HeLa cells 
expressing either shRNA for c-Src or a scrambled sequence (control) were analyzed for c-
Src expression (Anti-Total c-Src)  via Western blot.  B. Quantitation of the c-Src bands 
relative to actin.  C. HeLa cells expressing either shRNA for c-Src or scramble were 
transduced with AdV-β-Gal (MOI 100) for 1 h. β-Gal activity was analyzed 24 h later for 
four wells of cells per condition by β-galactosidase assay.  Error bars indicate standard 
error of the mean (SEM).  D. HeLa cells expressing either shRNA for c-Src or scramble 
were analyzed for CAR
Ex8
 (Anti-CAR
Ex8
-5678) or actin expression (loading control) via 
Western blot. (* = P < 0.0001; One-Way ANOVA; Tukey’s Post Hoc Test).   
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4.2.10 Knock down of c-Src kinase does not alter CAREx8 expression. 
 HeLa cells expressing shRNA for either c-Src or Scrambled shRNA were 
analyzed for CAREx8 expression via Western blot (Fig. 28D). CAREx8 abundance did not 
change with either shRNA vector, indicating that c-Src kinase does not play a role in 
CAREx8 expression.  
 
4.2.11 Broad inhibition of tyrosine protein kinases yields inconclusive results.   
 Src-family kinases are a group of non-receptor tyrosine kinases.  Thus in an 
attempt to develop a control for Src-family kinase inhibition with PP2, I examined the 
effects of broad tyrosine protein kinase inhibition on adenoviral transduction using 
genistein (a broad tyrosine protein kinase inhibitor).  CaLu-3 cells were treated with 
either DMSO (control) or increasing doses of genistein for 1 h.  The treated cells were 
then infected with adenovirus carrying the β-galactosidase reporter gene (MOI 100) for 1 
h, then washed and replenished with standard culture media containing the chemical 
inhibitor.  The cells were analyzed 24 h later via a β-galactosidase assay.  The CaLu-3 
cells showed a broad range of results (Fig. 29; p<0.001).  At lower concentrations of 
genistein, adenovirus infection was diminished, however, at higher concentrations of 
genistein, viral infection increased. From these data, it was determined that genistein has 
multiple effects on viral infection that deserves future attention, but is not an ideal 
control. 
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Figure 29. Broad inhibition of tyrosine kinases yields broad range in results.  
CaLu-3 cells were treated with genistein, a tyrosine protein kinase inhibitor, for 1 
h then transduced with AdV-β-Gal  (MOI 100) for 1 h. Cells were washed and 
replenished with standard growth media containing chemical inhibitor over 
night. β-galactosidase assay was performed 24 h later after transduction. β-Gal 
activity was assessed for four wells of cells per conditions by β-galactosidase 
assay.  Error bars indicate standard error of the mean (SEM). (* = P < 0.0001; 
One-Way ANOVA; Tukey’s Post Hoc Test).   
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4.3 Conclusion 
 From these data, I have shown that Src-family kinases do in fact play a role in 
adenovirus infection.  Here I show that inhibiting Src-family kinases decreases viral 
infection in a dose dependent manor and at an early stage of infection.  Alternatively, we 
show that extended Src-family kinase inhibition with PP2 further decreases both viral 
infection and CAREx8 expression at later time points.  However, CAREx8 expression 
remains unaffected by PP2 at early time points.  
 We then narrowed our scope and asked if adenovirus binding activates c-Src 
kinase specifically.  Here we show that c-Src kinase is activated within the first 60 
minutes of adenovirus infection.  Knowing that adenovirus activates c-Src kinase, and the 
inhibiting Src-family kinases decreases viral infection, we then asked if activating Src-
family kinases would help facilitate adenovirus infection or increase CAREx8 expression.  
However, activating Src-family kinases neither increased nor decreased viral infection or 
CAREx8 expression.   
 Lastly, we show that c-Src kinase is one of the specific family members involved 
in adenoviral infection.  This was shown by using a shRNA exclusively directed against 
c-Src kinase, which led to a substantial decrease in adenoviral infection.  It can be 
concluded that c-Src kinase plays a role relatively early on in adenoviral infection, 
although after viral entry.   Based on this data, one can state that c-Src is crucial for 
efficient viral transduction. 
 The limitation within the experimental designs lay with the conditional 
parameters such as the chemical inhibitors, activators, and controls used.  PP1 and PP2 
are small molecule chemical inhibitors for Src-family kinases.  Src-family kinases are 
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composed of nine family members, however these inhibitors are only specific to a few of 
the family members, and have varying specificities (Table 3 and 4).  Recently, a kinome 
study suggested that PP2 at a concentration of 10 µM was not that selective, showing that 
multiple kinases were displaced by an immobilized ligand bound by PP2 [48].  This 
suggests that PP2 has several off-site targets which may be affecting the results.  The Src 
activator used is a YEEI phosphopeptide that binds the SH2 domain of Src-family 
kinases.  SH2 domains are conserved among the Src-family members, and are responsible 
for recognizing and binding phosphor-tyrosine sequences on other proteins [49].  It is 
possible that the activator binding the SH2 domain blocks potential interactions with 
other proteins, thus rendering the kinase inactive for adenovirus infection.  Constitutively 
active Src-family kinases, by mutating the Y527 at the c-terminus of each family 
member, may serve as better approach to determine activated Src-family kinases role in 
CAR expression and adenoviral entry in the future.                    
  
 
 
 
 
 
 
 
 
 
	  78	  
Chapter 5. Discussion 
5.1 CAR Half life 
 Protein turnover plays an important role in cellular processes.  Knowing the rate 
at which a protein is degraded can have significant implications for the advancement of 
directed therapeutics in treating certain diseases.  It also provides insight into the 
mechanisms of how the protein is degraded.  In instances where there are several 
different isoforms of a protein, with differential localization of each separate isoform, and 
a varied concentration of each isoform under standard cellular conditions, knowing the 
half-life of each isoform could lend some understanding into protein function and 
regulation. Here we show that the half-life of CAREx7 is roughly 5 h whereas CAREx8 is 
roughly 2 h in polarized MDCK stable cells.  This is interesting in that CAR acts as the 
primary receptor for both the coxsackie B virus and most adenoviruses.  Specifically each 
CAR isoform has a distinct localization in polarized epithelial cells.  CAREx7 localizes at 
the basolateral surface where CAREx8 localizes at the apical surface or resides in 
subapical compartments [9].  Each CAR isoform has been shown to interact with MAGI-
1b [22, 50].  Interestingly, the PDZ1 and PDZ3 domains of MAGI-1b have been shown 
to play differential roles in CAREx8 regulation.   
 In this study we show that the two isoforms of CAR have varied half-lives.  This 
makes sense when put into context of structure and function within the cells.  CAREx7 is 
important for maintaining epithelial polarity at the basolateral surface by forming 
homophilic adhesions with corresponding CAREx7 molecules on adjacent cells. These 
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CAR-CAR-mediated hemophilic interactions between cells are thought to increase tight 
junction integrity [11, 13].  CAREx7 plays a critical role in neutrophil transepithelial 
migration by interacting with junction adhesion molecule like protein (JAM-L), an 
adhesion protein on the surface of neutrophils [51].   
In contrast, the function of CAREx8 and its role at the apical surface is still largely 
a mystery.  Since CAREx8 is capable of acting as the primary receptor for most 
adenoviruses, its unique localization at the apical surface of polarized airway epithelia 
provides an ideal opportunity for adenoviruses entering the lumen of the airway to initiate 
infection. It therefore makes logical sense for this particular isoform to be more tightly 
regulated, less abundant, and have a shorter half-life to protect the cells from viral 
infection.  
The regulation of each CAR isoform begins at the transcript level, which 
translates into further regulation at the protein level.  MAGI-1b acts as a scaffolding 
protein that interacts with the junctional proteins ZO-1, β-catenin, and CAREx7 [50, 52, 
53].  The longer half-life of CAREx7 could be attributed to it being a more functionally 
stable protein within complexes at the basolateral junctions, or varying protein 
interactions, including a stabilizing interaction with the scaffolding protein MAGI-1b at 
the tight junctions, or homophilic adhesion to other CAREx7 proteins on adjacent cells.  In 
contrast, CAREx8 has been shown to be negatively regulated by MAGI-1b and it is not yet 
known whether it is part of a protein complex when at the apical surface.  This could 
account for decreased protein stability thus a shorter half-life. 
 The short half-life of CAREx8 may also be a consequence of the protein’s native 
physiological role in neutrophil transmigration, a process that only requires CAREx8 to be 
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expressed in short transient bursts.  Recently it has been shown that the chemokine 
interlukin-8 (IL-8) increases CAREx8 expression at the apical surface of polarized 
epithelia [21].  In instances of potential infection in the airway, IL-8 serves as a 
chemoattractant, recruiting neutrophils to the site of infection.  Moreover, recent data 
from our lab suggest that CAREx8 is able to tether infiltrating neutrophils at the apical 
surface of the epithelium. Although this would increase the critical concentration of 
neutrophils and increase the killing of invading pathogens, prolonged residence on the 
epithelium may damage the host cells. A short half-life would limit the time of 
neutrophils at the apical surface and limit host-cell damage.  
 
5.2 CAR and Src-kinases 
 Cell signaling is a complex communication system that controls nearly every 
function within a cell. Signaling cascades are generated from the cells ability to sense and 
respond to external and internal environmental stimuli.  The ability for a cell to detect and 
react to changes within its external environment is critical for many essential processes 
such as growth and development, tissue repair, and immunity.  A defect in a cells ability 
to interact and respond to its environment can lead to the development of many diseases 
including  cancer, AIDS, and autoimmune disorders.  Understanding specific signaling 
cascades has major implications for understanding virus pathogenicity and has the 
potential to provide a platform for researchers to develop site directed therapeutics in 
order to treat certain diseases or prevent viral egress in infected individuals. 
 Recently Src-family kinases have been shown to play a role in viral infection and 
have been shown to interact with CAR at cell junctions and in sertoli germ cells [28, 33, 
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54].  It is also known that these kinases are involved in many cell signaling pathways 
[55]. Here I have shown that Src-family kinases do in fact play a role in the early stages 
of viral infection.  When Src-family kinases are inhibited, viral infection is limited or 
decreased, however the converse is not true.  Upregulation of Src-family kinases does not 
result in an increase in viral infection. I hypothesized that Src kinase inhibition decreased 
CAREx8 expression, however, when Src kinases were inhibited with PP1 or PP2, there 
was no detectable change in total CAREx8 levels at early time points.  Interestingly 
enough extended exposure to PP2 for more than 8 h showed a mild decrease in CAREx8 
expression and a substantial decrease in viral genomes entering the cells.  Even further 
exposure to PP2 for 24 h showed a more pronounced decrease in CAREx8 expression and 
adenovirus entry.  These occurrences may be specific and distantly regulate CAREx8 
expression. Alternatively, they may be due to off-site targeting of the chemical inhibitor 
instead of decreased Src-family kinase activity.  Off-target effects can be supported by 
the fact that when using shRNA specific for c-Src, there was no change in CAREx8 
expression in HeLa cells. However, PP2 is a broad small molecule inhibitor for Src-
family kinases.  Potentially the changes we see in cells that have had extended exposure 
to PP2 is either due to off-site targeting, or due to the inhibition of an alternative Src-
family kinase One such family is Hck and c-Src.  This stems from the fact that decreased 
CAREx8 expression was limited to PP2 alone, whereas PP1 showed no change.  As shown 
in Tables 3 and 4 the largest variance between the two small molecule inhibitors lies in 
the concentration of inhibitor needed to reduce the response or binding of the target by 
half (IC50) were for Hck and c-Src.  PP1 has an IC50 for Hck = 20 nM and c-Src = 170
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Table 3.  PP1 affinity for kinase targets. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PP1 target Affinity (IC50) Src-family kinase 
Lck 5 nM + 
Fyn 6 nM + 
Hck 20 nM + 
Src 170 nM + 
EGFR 250 nM - 
JAK2 50,000 nM - 
ZAP-70 600 nM - 
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Table 4.  PP2 affinity for kinase targets. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PP2 target Affinity (IC50) Src-family 
kinase 
Lck 4 nM + 
Fyn 5 nM + 
Hck 5 nM + 
Src 100 nM + 
EGFR 480 nM - 
JAK2 50,000 nM - 
ZAP-70 100,000 nM - 
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nM, whereas PP2 has an IC50 for Hck = 5 nM and c-Src = 100 nM (Bertin Pharma; 
Table 3 and 4) [56].  Even though viral entry and transduction were decreased by both 
PP1, PP2 and c-Src shRNA, Hck kinase may actually play a role in CAREx8 expression 
since c-Src shRNA had no effect on CAREx8 expression.    
 Despite no to limited late changes in CAREx8 protein expression, viral entry and 
transduction were decreased by both PP1 and PP2 and were decreased by the c-Src 
shRNA.  This suggests that the changes in adenoviral infection are directly correlated to 
Src inhibition.  Src has been shown to be involved with dynamin-mediated endocytosis 
and macropinocytosis. Recently, Morton et al., suggest that CAR potentially mediates Src 
signaling and that inhibiting Src with PP2 decreases CAR localization to vesicles.  
Alternatively, when Src is not being inhibited, it has been shown to localize with CAR at 
the cell junctions and in vesicles.   Adenovirus enters cells via receptor-mediated 
endocytosis in clathrin coated vesicles.  Due to CAR being the primary receptor for most 
adenoviruses, this suggests that Src activity is required for the adequate endocytosis of 
CAR-AdV. Which has further implications because when Src is inhibited or silenced, 
adenovirus is unable to be internalized by the host cells thus leading to decreased viral 
transduction. 
 Alternatively, Src inhibition was shown to redirect reovirus to the lysosome at an 
early point of infection where it was unable to replicate.  Here I show that, Src kinase 
inhibition only affects adenoviral transduction within the first hour after viral infection.  
There was no change in viral transduction efficiency when Src was inhibited prior to viral 
infection but not immediately after infection.  Additionally, inhibiting Src-family kinases 
1 h after the initial infection period did not affect viral transduction efficiency.  This 
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suggests that Src kinases play a critical role during viral trafficking.  Thus, inhibiting Src 
family kinases interrupts the ability of adenoviruses to successfully travel to the nucleus, 
instead potentially trafficking the virus to the lysosome where it is then degraded. 
 
5.3 Broader impacts and future studies 
 In human polarized epithelial cells, CAREx8 localizes to the apical surface where it 
is accessible for viral infection. Preliminary data shows that the inhibition of Src-family 
kinase using the small molecule inhibitor PP2 decreases adenoviral infection. This 
research will help narrow down which endogenous mechanisms regulate CAR expression 
and localization.  Insight may be provided to future researchers as well as medical 
professionals as to why a viral receptor would localize at the apical surface of epithelia - 
a high-risk area for viral contact upon the inhalation of droplets that potentially contain 
viruses suspended in the air (i.e. sneezes).  Identification and investigation of the 
signaling pathways involved in adenoviral entry from the airway lumen will allow for the 
identification of novel therapeutic targets that can 1) aid in the advancement of 
adenoviral mediated gene therapy to treat lung disorders such as cystic fibrosis and 
asthma; and 2) aid in mapping out a way to decrease the susceptibility of the population 
to adenoviral infections 
 
Future directions 
 Preliminary data strongly supports the hypotheses that the Src family kinases are 
involved with adenoviral infection but do not acutely affect CAREx8 expression.  If the 
inhibition of Src family kinases proves to not play a role in the trafficking of internalized 
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virus, then an alternative hypothesis would be that the Src family kinases are involved 
with integrin localization and/or cell signaling. Src family kinases may also play a role in 
viral disassembly or viral DNA expression (Fig. 30). If the MDCK stable cells prove to 
not be an ideal model of CAREx8 expression, turnover, and degradation, then other 
avenues involving radiolabeled endogenous CAREx8 will be explored.
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Figure 30. Model of Src-family kinase inhibition hypotheses. 
Inhibiting Src-family kinases does one or a combination of the following: 1. 
Decreases CAR
Ex8
 at the apical surface of polarized epithelia.  2. Inhibits 
internalization of bound virus.  3. Targets internalized virus to the lysosome. 
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